Table of Contents Author Guidelines Submit a Manuscript
Journal of Lipids
Volume 2015, Article ID 971453, 50 pages
http://dx.doi.org/10.1155/2015/971453
Review Article

Emerging Risk Biomarkers in Cardiovascular Diseases and Disorders

Department of Zoology, DDU Gorakhpur University, Gorakhpur 273009, India

Received 19 November 2014; Revised 24 February 2015; Accepted 25 February 2015

Academic Editor: Javier S. Perona

Copyright © 2015 Ravi Kant Upadhyay. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Bamba, “Update on screening, etiology, and treatment of dyslipidemia in children,” The Journal of Clinical Endocrinology & Metabolism, vol. 99, no. 9, pp. 3093–3102, 2014. View at Google Scholar
  2. N. Brucker, M. F. Charão, A. M. Moro et al., “Atherosclerotic process in taxi drivers occupationally exposed to air pollution and co-morbidities,” Environmental Research, vol. 131, pp. 31–38, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. T. M. Brown and V. Bittner, “Biomarkers of atherosclerosis: clinical applications,” Current Cardiology Reports, vol. 10, no. 6, pp. 497–504, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. A. Cooper, G. J. Miller, and S. E. Humphries, “A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study,” Atherosclerosis, vol. 181, no. 1, pp. 93–100, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. S. M. Grundy, R. B. D'Agostino Sr., L. Mosca et al., “Cardiovascular risk assessment based on US cohort studies: findings from a National Heart, Lung, and Blood Institute Workshop,” Circulation, vol. 104, no. 4, pp. 491–496, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Kalantarian, E. B. Rimm, D. M. Herrington, and D. Mozaffarian, “Dietary macronutrients, genetic variation, and progression of coronary atherosclerosis among women,” American Heart Journal, vol. 167, no. 4, pp. 627.e1–635.e1, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Shao, C. Tang, A. Sinha et al., “Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase,” Circulation Research, vol. 114, no. 11, pp. 1733–1742, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. L. A. Distiller, “Why do some patients with type 1 diabetes live so long?” World Journal of Diabetes, vol. 5, no. 3, pp. 282–287, 2014. View at Publisher · View at Google Scholar
  9. T. Mueller, F. Hinterreiter, C. Luft, W. Poelz, M. Haltmayer, and B. Dieplinger, “Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes,” Journal of Vascular Surgery, vol. 59, no. 5, pp. 1291–1299, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Unis, A. Abdelbary, and M. Hamza, “Comparison of the effects of escitalopram and atorvastatin on diet-induced atherosclerosis in rats,” Canadian Journal of Physiology and Pharmacology, vol. 92, no. 3, pp. 226–233, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. N. R. Hadi, B. I. Mohammad, I. M. Ajeena, and H. H. Sahib, “Antiatherosclerotic potential of clopidogrel: antioxidant and anti-inflammatory approaches,” BioMed Research International, vol. 2013, Article ID 790263, 10 pages, 2013. View at Publisher · View at Google Scholar
  12. P. Collier, C. J. Watson, V. Voon et al., “Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure?” European Journal of Heart Failure, vol. 13, no. 10, pp. 1087–1095, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. M. A. Kachkovskiǐ, V. V. Simerzin, O. A. Rybanenko, and N. A. Kirichenko, “Hemostasiological, lipidemic, and hemodynamic indicators associated with the risk of cardiovascular death in high- and very high-risk patients according to the SCORE scale,” Terapevticheskiǐ arkhiv, vol. 86, no. 3, pp. 59–64, 2014. View at Google Scholar · View at Scopus
  14. S. P. Whelton, V. Narla, M. J. Blaha et al., “Association between resting heart rate and inflammatory biomarkers (high-sensitivity c-reactive protein, interleukin-6, and fibrinogen) (from the multi-ethnic study of atherosclerosis),” The American Journal of Cardiology, vol. 113, no. 4, pp. 644–649, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Rubenfire and R. D. Brook, “HDL cholesterol and cardiovascular outcomes: what is the evidence?” Current Cardiology Reports, vol. 15, no. 4, article 349, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. A. L. Catapano, A. Pirillo, F. Bonacina, and G. D. Norata, “HDL in innate and adaptive immunity,” Cardiovascular Research, vol. 103, no. 3, pp. 372–383, 2014. View at Publisher · View at Google Scholar
  17. A. Zampetaki, P. Willeit, L. Tilling et al., “Prospective study on circulating microRNAs and risk of myocardial infarction,” Journal of the American College of Cardiology, vol. 60, no. 4, pp. 290–299, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. C. von Schacky, “Omega-3 index and cardiovascular health,” Nutrients, vol. 6, no. 2, pp. 799–814, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Heringlake, E. I. Charitos, N. Gatz et al., “Growth differentiation factor 15: a novel risk marker adjunct to the EuroSCORE for risk stratification in cardiac surgery patients,” Journal of the American College of Cardiology, vol. 61, no. 6, pp. 672–681, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. S. M. Grundy, “Use of emerging lipoprotein risk factors in assessment of cardiovascular risk,” The Journal of the American Medical Association, vol. 307, no. 23, pp. 2540–2542, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Luo, H. Ren, J.-B. Wan et al., “Enriched endogenous omega-3 fatty acids in mice protect against global ischemia injury,” The Journal of Lipid Research, vol. 55, no. 7, pp. 1288–1297, 2014. View at Publisher · View at Google Scholar
  22. E. Esposito, M. Cordaro, and S. Cuzzocrea, “Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury,” Pharmacological Research, vol. 86, pp. 26–31, 2014. View at Publisher · View at Google Scholar
  23. M. Hanefeld, E. Duetting, and P. Bramlage, “Cardiac implications of hypoglycaemia in patients with diabetes—a systematic review,” Cardiovascular Diabetology, vol. 12, no. 1, article 135, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. J. S. Y. Tan, C. J. P. Seow, V. J. Goh, and D. L. Silver, “Recent advances in understanding proteins involved in lipid droplet formation, growth and fusion,” Journal of Genetics and Genomics, vol. 41, no. 5, pp. 251–259, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Gupta, R. Gudapati, K. Gaurav, and M. Bhise, “Emerging risk factors for cardiovascular diseases: Indian context,” Indian Journal of Endocrinology and Metabolism, vol. 17, no. 5, pp. 806–814, 2013. View at Publisher · View at Google Scholar
  26. J. W. Rich-Edwards, A. Fraser, D. A. Lawlor, and J. M. Catov, “Pregnancy characteristics and women's future cardiovascular health: an underused opportunity to improve women's health?” Epidemiologic Reviews, vol. 36, no. 1, pp. 57–70, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. C. J. Hodcroft, M. C. Rossiter, and A. N. Buch, “Cannabis-associated myocardial infarction in a young man with normal coronary arteries,” The Journal of Emergency Medicine, vol. 47, no. 3, pp. 277–281, 2014. View at Publisher · View at Google Scholar
  28. S. D. Weiner, H. N. Ahmed, Z. Jin et al., “Systemic inflammation and brachial artery endothelial function in the Multi-Ethnic Study of Atherosclerosis (MESA),” Heart, vol. 100, no. 11, pp. 862–866, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Hurks, A. Vink, I. E. Hoefer et al., “Atherosclerotic risk factors and atherosclerotic postoperative events are associated with low inflammation in abdominal aortic aneurysms,” Atherosclerosis, vol. 235, no. 2, pp. 632–641, 2014. View at Publisher · View at Google Scholar
  30. E. T. Oni, A. S. Agatston, M. J. Blaha et al., “A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?” Atherosclerosis, vol. 230, no. 2, pp. 258–267, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Nursalim, M. Suryaatmadja, and M. Panggabean, “Potential clinical application of novel cardiac biomarkers for acute myocardial infarction,” Acta Medica Indonesiana, vol. 45, no. 3, pp. 240–250, 2013. View at Google Scholar · View at Scopus
  32. K. M. Eggers, J. Al-Shakarchi, L. Berglund et al., “High-sensitive cardiac troponin T and its relations to cardiovascular risk factors, morbidity, and mortality in elderly men,” American Heart Journal, vol. 166, no. 3, pp. 541.e1–548.e1, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. R. G. O'Malley, M. P. Bonaca, B. M. Scirica et al., “Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis in Myocardial Infarction 36),” Journal of the American College of Cardiology, vol. 63, no. 16, pp. 1644–1653, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Lippi and G. Cervellin, “Risk assessment of post-infarction heart failure. Systematic review on the role of emerging biomarkers,” Critical Reviews in Clinical Laboratory Sciences, vol. 51, no. 1, pp. 13–29, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Miner, A. Nehra, G. Jackson et al., “All men with vasculogenic erectile dysfunction require a cardiovascular workup,” The American Journal of Medicine, vol. 127, no. 3, pp. 174–182, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. Q. Zhang, X. Xiao, M. Li et al., “Berberine moderates glucose metabolism through the GnRH-GLP-1 and MAPK pathways in the intestine,” BMC Complementary and Alternative Medicine, vol. 14, no. 1, p. 188, 2014. View at Google Scholar
  37. E. O'Meara, S. de Denus, J.-L. Rouleau, and A. Desai, “Circulating biomarkers in patients with heart failure and preserved ejection fraction,” Current Heart Failure Reports, vol. 10, no. 4, pp. 350–358, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Samad and W. Ruf, “Inflammation, obesity, and thrombosis,” Blood, vol. 122, no. 20, pp. 3415–3422, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. R. López-Mejías, F. Genre, C. González-Juanatey, and M. A. González-Gay, “Autoantibodies and biomarkers of endothelial cell activation in atherosclerosis,” Vasa, vol. 43, no. 2, pp. 83–85, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. T. J. Saunders, J.-P. Chaput, and M. S. Tremblay, “Sedentary behaviour as an emerging risk factor for cardiometabolic diseases in children and youth,” Canadian Journal of Diabetes, vol. 38, no. 1, pp. 53–61, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Sakurai and H. Hanyu, “Lipid abnormality,” Nihon Rinsho, vol. 72, no. 4, pp. 697–701, 2014. View at Google Scholar · View at Scopus
  42. A. I. Paltsev, V. S. Myakotnykh, and M. N. Torgashov, “Blood lipid parameters in combat veterans with posttraumatic stress disorders,” Terapevticheskiǐ arkhiv, vol. 86, no. 2, pp. 56–62, 2014 (Russian). View at Google Scholar · View at Scopus
  43. I. Chopra and K. M. Kamal, “Factors associated with therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia,” Hospital Practice, vol. 42, no. 2, pp. 77–88, 2014. View at Google Scholar · View at Scopus
  44. A. Baszczuk, K. Musialik, J. Kopczyński et al., “Hyperhomocysteinemia, lipid and lipoprotein disturbances in patients with primary hypertension,” Advances in Medical Sciences, vol. 59, no. 1, pp. 68–73, 2014. View at Publisher · View at Google Scholar
  45. R. Bradley, A. L. Fitzpatrick, N. S. Jenny, D.-H. Lee, and D. R. Jacobs Jr., “Associations between total serum GGT activity and metabolic risk: MESA,” Biomarkers in Medicine, vol. 7, no. 5, pp. 709–721, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. I.-T. Lee, C.-Y. Wang, C.-N. Huang, C.-C. Fu, and W. H.-H. Sheu, “High triglyceride-to-HDL cholesterol ratio associated with albuminuria in type 2 diabetic subjects,” Journal of Diabetes and Its Complications, vol. 27, no. 3, pp. 243–247, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. B. Daubail, J. Durier, A. Jacquin et al., “Factors associated with early recurrence at the first evaluation of patients with transient ischemic attack,” Journal of Clinical Neuroscience, vol. 21, no. 11, pp. 1940–1944, 2014. View at Publisher · View at Google Scholar
  48. K. Zhi, M. Li, X. Zhang et al., “α4β7 integrin (LPAM-1) is upregulated at atherosclerotic lesions and is involved in atherosclerosis progression,” Cellular Physiology and Biochemistry, vol. 33, no. 6, pp. 1876–1887, 2014. View at Publisher · View at Google Scholar
  49. M. Jaiswal, A. Schinske, and R. Pop-Busui, “Lipids and lipid management in diabetes,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 28, no. 3, pp. 325–338, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. O. Mitu, M. Roca, M. M. Leon, and F. Mitu, “Predictive value of a positive exercise stress testing and correlations withcardiovascular risk factors,” Revista Medico-Chirurgicala a Societatii de Medici si Naturalisti din Iasi, vol. 118, no. 1, pp. 57–62, 2014. View at Google Scholar
  51. E. Orenes-Piñero, S. Manzano-Fernández, Á. López-Cuenca, F. Marín, M. Valdés, and J. L. Januzzi, “β -trace protein: from GFR marker to cardiovascular risk predictor,” Clinical Journal of the American Society of Nephrology, vol. 8, no. 5, pp. 873–881, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Arafah, R. Longuespée, A. Desmons, O. Kerdraon, I. Fournier, and M. Salzet, “Lipidomics for clinical diagnosis: dye-assisted laser desorption/ionization (DALDI) method for lipids detection in MALDI mass spectrometry imaging,” OMICS, vol. 18, no. 8, pp. 487–498, 2014. View at Publisher · View at Google Scholar
  53. F. di Girolamo, F. del Chierico, G. Caenaro, I. Lante, M. Muraca, and L. Putignani, “Human serum proteome analysis: new source of markers in metabolic disorders,” Biomarkers in Medicine, vol. 6, no. 6, pp. 759–773, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. K.-A. Rye, “Biomarkers associated with high-density lipoproteins in atherosclerotic kidney disease,” Clinical and Experimental Nephrology, vol. 18, no. 2, pp. 247–250, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Ahmadzadeh and F. Azizi, “Genes associated with low serum high-density lipoprotein cholesterol,” Archives of Iranian Medicine, vol. 17, no. 6, pp. 444–450, 2014. View at Google Scholar
  56. H. Ajdarkosh, M. R. Khansari, M. R. Sohrabi et al., “Thyroid dysfunction and choleduocholithiasis,” Middle East Journal of Digestive Diseases, vol. 5, no. 3, pp. 141–145, 2013. View at Google Scholar
  57. J. Wu, H. Zhang, H. Zheng, and Y. Jiang, “Hepatic inflammation scores correlate with common carotid intima-media thickness in rats with NAFLD induced by a high-fat diet,” BMC Veterinary Research, vol. 10, no. 1, p. 162, 2014. View at Publisher · View at Google Scholar
  58. S. Fonville, A. A. Zandbergen, P. J. Koudstaal, and H. M. den Hertog, “Prediabetes in patients with stroke or transient ischemic attack: prevalence, risk and clinical management,” Cerebrovascular Diseases, vol. 37, no. 6, pp. 393–400, 2014. View at Publisher · View at Google Scholar
  59. S. Virupannavar, A. Brandau, C. Guggenheim, and H. Laird-Fick, “Possible association of etanercept, venous thrombosis, and induction of antiphospholipid syndrome,” Case Reports in Rheumatology, vol. 2014, Article ID 801072, 4 pages, 2014. View at Publisher · View at Google Scholar
  60. Y. Peng, “Expert consensus on blood pressure management of diabetic patients in China,” Journal of Diabetes, vol. 6, no. 3, pp. 202–211, 2014. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Bowring, M. Mahto, D. Mandal, and P. N. Baker, “Stroke in pregnancy associated with syphilis,” Journal of Obstetrics and Gynaecology Research, vol. 34, no. 3, pp. 405–407, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. C. Mihl, D. Loeffen, M. O. Versteylen et al., “Automated quantification of epicardial adipose tissue (EAT) in coronary CT angiography; comparison with manual assessment and correlation with coronary artery disease,” Journal of Cardiovascular Computed Tomography, vol. 8, no. 3, pp. 215–221, 2014. View at Publisher · View at Google Scholar
  63. C. P. Y. Chan and T. H. Rainer, “Pathophysiological roles and clinical importance of biomarkers in acute coronary syndrome,” Advances in Clinical Chemistry, vol. 59, pp. 23–63, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Kew, J. K. Hamilton, C. Ye, A. J. Hanley, B. Zinman, and R. Retnakaran, “Vitamin D status and cardiometabolic assessment in infancy,” Pediatric Research, vol. 74, no. 2, pp. 217–222, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. N. Sillanpää, “Role of perfusion imaging in acute stroke,” Panminerva Medica, vol. 55, no. 1, pp. 29–41, 2013. View at Google Scholar · View at Scopus
  66. M. F. Feitosa, M. K. Wojczynski, R. Straka et al., “Genetic analysis of long-lived families reveals novel variants influencing high density-lipoprotein cholesterol,” Frontiers in Genetics, vol. 5, p. 159, 2014. View at Publisher · View at Google Scholar
  67. S. C. van den Oord, Z. Akkus, G. Renaud et al., “Assessment of carotid atherosclerosis, intraplaque neovascularization, and plaque ulceration using quantitative contrast-enhanced ultrasound in asymptomatic patients with diabetes mellitus,” European Heart Journal—Cardiovascular Imaging, vol. 15, no. 11, pp. 1213–1218, 2014. View at Google Scholar
  68. A. K. Ramaswamy, M. Hamilton, R. V. Joshi et al., “Molecular imaging of experimental abdominal aortic aneurysms,” The Scientific World Journal, vol. 2013, Article ID 973150, 18 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. S. Mavrogeni, P. P. Sfikakis, T. Dimitroulas, G. Kolovou, and G. D. Kitas, “Cardiac and muscular involvement in idiopathic inflammatory myopathies: noninvasive diagnostic assessment and the role of cardiovascular and skeletal magnetic resonance imaging,” Inflammation & Allergy-Drug Targets, vol. 13, no. 3, pp. 206–216, 2014. View at Publisher · View at Google Scholar
  70. F. S. Apple, L. M. Steffen, L. A. Pearce, M. M. Murakami, and R. V. Luepker, “Increased cardiac troponin i as measured by a high-sensitivity assay is associated with high odds of cardiovascular death: the Minnesota Heart Survey,” Clinical Chemistry, vol. 58, no. 5, pp. 930–935, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. A. R. Naylor, “Identifying the high-risk carotid plaque,” Journal of Cardiovascular Surgery, vol. 55, no. 2, pp. 11–20, 2014. View at Google Scholar · View at Scopus
  72. D. Shahmirzadi and E. E. Konofagou, “Quantification of arterial wall inhomogeneity size, distribution, and modulus contrast using FSI numerical pulse wave propagation,” Artery Research, vol. 8, no. 2, pp. 57–65, 2014. View at Publisher · View at Google Scholar · View at Scopus
  73. O. A. Ali, M. Chapman, T. H. Nguyen et al., “Interactions between inflammatory activation and endothelial dysfunction selectively modulate valve disease progression in patients with bicuspid aortic valve,” Heart, vol. 100, no. 10, pp. 800–805, 2014. View at Publisher · View at Google Scholar · View at Scopus
  74. F. Bourier, R. Fahrig, P. Wang et al., “Accuracy assessment of catheter guidance technology in electrophysiology procedures: a comparison of a new 3D-based fluoroscopy navigation system to current electroanatomic mapping systems,” Journal of Cardiovascular Electrophysiology, vol. 25, no. 1, pp. 74–83, 2014. View at Publisher · View at Google Scholar · View at Scopus
  75. I. Makedonov, S. E. Black, and B. J. MacIntosh, “BOLD fMRI in the white matter as a marker of aging and small vessel disease,” PLoS ONE, vol. 8, no. 7, Article ID e67652, 2013. View at Publisher · View at Google Scholar · View at Scopus
  76. B. A. Berkowitz, D. Bissig, O. Dutczak, S. Corbett, R. North, and R. Roberts, “MRI biomarkers for evaluation of treatment efficacy in preclinical diabetic retinopathy,” Expert Opinion on Medical Diagnostics, vol. 7, no. 4, pp. 393–403, 2013. View at Publisher · View at Google Scholar · View at Scopus
  77. Y. Zheng, L. Wang, T. M. Krupka et al., “The feasibility of using high frequency ultrasound to assess nerve ending neuropathy in patients with diabetic foot,” European Journal of Radiology, vol. 82, no. 3, pp. 512–517, 2013. View at Publisher · View at Google Scholar · View at Scopus
  78. M. A. de Graaf, A. Broersen, P. H. Kitslaar et al., “Automatic quantification and characterization of coronary atherosclerosis with computed tomography coronary angiography: cross-correlation with intravascular ultrasound virtual histology,” International Journal of Cardiovascular Imaging, vol. 29, no. 5, pp. 1177–1190, 2013. View at Publisher · View at Google Scholar · View at Scopus
  79. T. H. Osaki, F. A. Jakobiec, P. R. Mendoza, Y. Lee, and A. M. Fay, “Immunohistochemical investigations of orbital infantile hemangiomas and adult encapsulated cavernous venous lesions (Malformation versus hemangioma),” Ophthalmic Plastic and Reconstructive Surgery, vol. 29, no. 3, pp. 183–195, 2013. View at Publisher · View at Google Scholar · View at Scopus
  80. Y. Zhan, J. Yu, R. Ding, Y. Sun, and D. Hu, “Triglyceride to high density lipoprotein cholesterol ratio, total cholesterol to high density lipoprotein cholesterol ratio and low ankle brachial index in an elderly population,” Vasa, vol. 43, no. 3, pp. 189–197, 2014. View at Publisher · View at Google Scholar · View at Scopus
  81. O. Fekih, S. Triki, I. Hellara et al., “Can paraoxonase 1 polymorphisms (L55 M and Q192 R) protect children with type 1 diabetes against lipid abnormalities?” Journal of Clinical Lipidology, vol. 8, no. 3, pp. 249–255, 2014. View at Publisher · View at Google Scholar · View at Scopus
  82. A. J. Lepedda, A. Zinellu, G. Nieddu et al., “Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 690953, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  83. C. C. Y. Chang, H. Y. Huh, K. M. Cadigan, and T. Y. Chang, “Molecular cloning and functional expression of human acyl-coenzyme A:cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells,” The Journal of Biological Chemistry, vol. 268, no. 28, pp. 20747–20755, 1993. View at Google Scholar · View at Scopus
  84. J. Armando, J. F. Mendez Oram, and E. L. Bieman, “Protein kinase C as a mediator of high density lipoprotein receptor dependent efflux of intracellular cholesterol,” The Journal of Biological Chemistry, vol. 266, no. 5, pp. 10104–10111, 1991. View at Google Scholar
  85. W. C. Miller, R. C. Hickson, and N. M. Bass, “Fatty acid binding proteins in the three types of rat skeletal muscle,” Proceedings of the Society for Experimental Biology and Medicine, vol. 189, no. 2, pp. 183–188, 1988. View at Publisher · View at Google Scholar · View at Scopus
  86. J. Sakai and R. B. Rawson, “The sterol regulatory element-binding protein pathway: control of lipid homeostasis through regulated intracellular transport,” Current Opinion in Lipidology, vol. 12, no. 3, pp. 261–266, 2001. View at Publisher · View at Google Scholar · View at Scopus
  87. N. H. Haunerland, P. Andolfatto, J. M. Chisholm, Z. Wang, and X. Chen, “Development changes in muscle FABP expression concentration and intracellular distribution in the desert locust, Schistocerca gregaria,” European Journal of Biochemistry, vol. 201, pp. 1045–1051, 1992. View at Google Scholar
  88. M. Shokrani, “Emerging approaches to the examination of lipoproteins for cardio-metabolic risk stratification,” MLO: Medical Laboratory Observer, vol. 46, no. 1, pp. 16–17, 2014. View at Google Scholar · View at Scopus
  89. C. V. S. Ram, “Fixed-dose triple-combination treatments in the management of hypertension,” Managed Care, vol. 22, no. 12, pp. 45–55, 2013. View at Google Scholar · View at Scopus
  90. M. Stenovec, S. Trkov, M. Kreft, and R. Zorec, “Alterations of calcium homoeostasis in cultured rat astrocytes evoked by bioactive sphingolipids,” Acta Physiologica, vol. 212, no. 1, pp. 49–61, 2014. View at Publisher · View at Google Scholar · View at Scopus
  91. R. Ohkawa, M. Kurano, K. Nakamura et al., “Sphingolipids, possible biomarkers for atherosclerotic disorders,” Rinsho Byori, vol. 61, no. 9, pp. 795–802, 2013. View at Google Scholar · View at Scopus
  92. C. Ehnholm, R. W. Mahley, D. A. Chappell, K. H. Weisgraber, E. Ludwig, and J. L. Witztum, “Role of apolipoprotein E in the lipolytic conversion of β-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 81, no. 17, pp. 5566–5570, 1984. View at Publisher · View at Google Scholar · View at Scopus
  93. B. Li, W. Lin, N. Lin, X. Dong, and L. Liu, “Study of the correlation between serum ferritin levels and the aggregation of metabolic disorders in non-diabetic elderly patients,” Experimental and Therapeutic Medicine, vol. 7, no. 6, pp. 1671–1676, 2014. View at Publisher · View at Google Scholar · View at Scopus
  94. A. Neuville, F. Collin, P. Bruneval et al., “Intimal sarcoma is the most frequent primary cardiac sarcoma: clinicopathologic and molecular retrospective analysis of 100 primary cardiac sarcomas,” The American Journal of Surgical Pathology, vol. 38, no. 4, pp. 461–469, 2014. View at Publisher · View at Google Scholar
  95. H. Wulf-Johansson, S. L. Johansson, A. Schlosser et al., “Localization of microfibrillar-associated protein 4 (MFAP4) in human tissues: clinical evaluation of serum MFAP4 and its association with various cardiovascular conditions,” PLoS ONE, vol. 8, no. 12, Article ID e82243, 2013. View at Publisher · View at Google Scholar · View at Scopus
  96. Y.-S. Kwon, T. I. Park, Y. Cho, M. H. Bae, and S. Kim, “Clinical usefulness of immunohistochemistry for plakoglobin, N-cadherin, and connexin-43 in the diagnosis of arrhythmogenic right ventricular cardiomyopathy,” International Journal of Clinical and Experimental Pathology, vol. 6, no. 12, pp. 2928–2935, 2013. View at Google Scholar · View at Scopus
  97. N. C. Akdur, M. Donmez, S. Gozel, H. Ustun, and S. Hucumenoglu, “Intravascular papillary endothelial hyperplasia: histomorphological and immunohistochemical features,” Diagnostic Pathology, vol. 8, no. 1, article 167, 2013. View at Publisher · View at Google Scholar · View at Scopus
  98. R. K. Upadhyay and H. C. Agarwal, “Role of lipoproteins in cholesterol trafficking in insects: a review,” Journal of Applied Biosciences, vol. 33, no. 2, pp. 96–110, 2007. View at Google Scholar
  99. W. M. Pandak, D. Rodriguez-Agudo, S. Ren et al., “Localization of StarD5 cholesterol binding protein,” Journal of Lipid Research, vol. 47, no. 6, pp. 1168–1175, 2006. View at Publisher · View at Google Scholar · View at Scopus
  100. X. R. Guo, S. C. Zheng, L. Liu, and Q. L. Feng, “The sterol carrier protein 2/3-oxoacyl-CoA thiolase (SCPx) is involved in cholesterol uptake in the midgut of Spodoptera litura: Gene cloning, expression, localization and functional analyses,” BMC Molecular Biology, vol. 10, article 102, 2009. View at Publisher · View at Google Scholar · View at Scopus
  101. J.-H. Kim and W.-Y. Ong, “Localization of the transcription factor, sterol regulatory element binding protein-2 (SREBP-2) in the normal rat brain and changes after kainate-induced excitotoxic injury,” Journal of Chemical Neuroanatomy, vol. 37, no. 2, pp. 71–77, 2009. View at Publisher · View at Google Scholar · View at Scopus
  102. A. Piwowar, “Biochemical and clinical aspects of advanced oxidation protein products in kidney diseases and metabolic disturbances,” Postępy Higieny i Medycyny Doświadczalnej, vol. 68, pp. 179–190, 2014. View at Publisher · View at Google Scholar
  103. C.-Y. Cheng, S.-Y. Su, N.-Y. Tang, T.-Y. Ho, S.-Y. Chiang, and C.-L. Hsieh, “Ferulic acid provides neuroprotection against oxidative stress-related apoptosis after cerebral ischemia/reperfusion injury by inhibiting ICAM-1 mRNA expression in rats,” Brain Research, vol. 1209, pp. 136–150, 2008. View at Publisher · View at Google Scholar · View at Scopus
  104. L. Méndez, M. Pazos, M. Giralt et al., “Targets of protein carbonylation in spontaneously hypertensive obese Koletsky rats and healthy Wistar counterparts: a potential role on metabolic disorders,” Journal of Proteomics, vol. 25, no. 106, pp. 246–259, 2014. View at Publisher · View at Google Scholar · View at Scopus
  105. S. Dzięgielewska-Gęsiak, E. Wysocka, S. Michalak, E. Nowakowska-Zajdel, T. Kokot, and M. Muc-Wierzgoń, “Role of lipid peroxidation products, plasma total antioxidant status, and Cu-, Zn-superoxide dismutase activity as biomarkers of oxidative stress in elderly prediabetics,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 987303, 8 pages, 2014. View at Publisher · View at Google Scholar
  106. E. Miller, A. Morel, L. Saso, and J. Saluk, “Isoprostanes and neuroprostanes as biomarkers of oxidative stress in neurodegenerative diseases,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 572491, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  107. L. Stoner, A. A. Lucero, B. R. Palmer, L. M. Jones, J. M. Young, and J. Faulkner, “Inflammatory biomarkers for predicting cardiovascular disease,” Clinical Biochemistry, vol. 46, no. 15, pp. 1353–1371, 2013. View at Publisher · View at Google Scholar · View at Scopus
  108. J. Rolin and A. A. Maghazachi, “Implications of chemokines, chemokine receptors, and inflammatory lipids in atherosclerosis,” Journal of Leukocyte Biology, vol. 95, no. 4, pp. 575–585, 2014. View at Publisher · View at Google Scholar · View at Scopus
  109. D. H. Farrell, “γ′ Fibrinogen as a novel marker of thrombotic disease,” Clinical Chemistry and Laboratory Medicine, vol. 50, no. 11, pp. 1903–1909, 2012. View at Publisher · View at Google Scholar · View at Scopus
  110. S. Willems, I. Hoefer, and G. Pasterkamp, “The role of the Interleukin 1 receptor-like 1 (ST2) and Interleukin-33 pathway in cardiovascular disease and cardiovascular risk assessment,” Minerva Medica, vol. 103, no. 6, pp. 513–523, 2012. View at Google Scholar · View at Scopus
  111. L. M. Beaulieu, E. Lin, E. Mick et al., “Interleukin 1 receptor 1 and interleukin 1β regulate megakaryocyte maturation, platelet activation, and transcript profile during inflammation in mice and humans,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 3, pp. 552–564, 2014. View at Publisher · View at Google Scholar · View at Scopus
  112. N. R. Desai, P. Kohli, R. P. Giugliano et al., “AMG145, a monoclonal antibody against proprotein convertase subtilisin kexin type 9, significantly reduces lipoprotein(a) in hypercholesterolemic patients receiving statin therapy: an analysis from the LDL-C assessment with proprotein convertase subtilisin kexin type 9 monoclonal antibody inhibition combined with statin therapy (LAPLACE)-thrombolysis in myocardial infarction (TIMI) 57 Trial,” Circulation, vol. 128, no. 9, pp. 962–969, 2013. View at Publisher · View at Google Scholar · View at Scopus
  113. T. Torres, N. Bettencourt, D. Mendonça, C. Vasconcelos, B. M. Silva, and M. Selores, “Complement C3 as a marker of cardiometabolic risk in psoriasis,” Archives of Dermatological Research, vol. 306, no. 7, pp. 653–660, 2014. View at Publisher · View at Google Scholar · View at Scopus
  114. H. P. Luehmann, E. D. Pressly, L. Detering et al., “PET/CT imaging of chemokine receptor CCR5 in vascular injury model using targeted nanoparticle,” Journal of Nuclear Medicine, vol. 55, no. 4, pp. 629–634, 2014. View at Publisher · View at Google Scholar · View at Scopus
  115. A. Stålman, D. Bring, and P. W. Ackermann, “Chemokine expression of CCL2, CCL3, CCL5 and CXCL10 during early inflammatory tendon healing precedes nerve regeneration: an immunohistochemical study in the rat,” Knee Surgery, Sports Traumatology, Arthroscopy, 2014. View at Publisher · View at Google Scholar · View at Scopus
  116. A. L. Hardaway and I. Podgorski, “IL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies,” Future Medicinal Chemistry, vol. 5, no. 10, pp. 1089–1108, 2013. View at Publisher · View at Google Scholar · View at Scopus
  117. R. J. B. Nibbs and G. J. Graham, “Immune regulation by atypical chemokine receptors,” Nature Reviews Immunology, vol. 13, no. 11, pp. 815–829, 2013. View at Publisher · View at Google Scholar · View at Scopus
  118. B. S. Lee, S. H. Kim, J. Oh et al., “C-reactive protein inhibits survivin expression via Akt/mTOR pathway downregulation by PTEN expression in cardiac myocytes,” PLoS ONE, vol. 9, no. 5, Article ID e98113, 2014. View at Publisher · View at Google Scholar · View at Scopus
  119. G. K. Marathe, C. Pandit, C. L. Lakshmikanth, V. H. Chaithra, S. P. Jacob, and C. J. M. D'Souza, “To hydrolyse or not to hydrolyse: the dilemma of platelet activating factor acetylhydrolase (PAF-AH),” The Journal of Lipid Research, vol. 55, no. 9, pp. 1847–1854, 2014. View at Publisher · View at Google Scholar
  120. O. S. Dhillon, H. K. Narayan, P. A. Quinn, I. B. Squire, J. E. Davies, and L. L. Ng, “Interleukin 33 and ST2 in non-ST-elevation myocardial infarction: comparison with Global Registry of Acute Coronary Events Risk Scoring and NT-proBNP,” American Heart Journal, vol. 161, no. 6, pp. 1163–1170, 2011. View at Publisher · View at Google Scholar · View at Scopus
  121. V. C. Vasile and A. S. Jaffe, “Emerging biomarkers for acute heart conditions,” Current Opinion in Cardiology, vol. 29, no. 4, pp. 312–318, 2014. View at Google Scholar
  122. J. L. Januzzi Jr., “ST2 as a cardiovascular risk biomarker: from the bench to the bedside,” Journal of Cardiovascular Translational Research, vol. 6, no. 4, pp. 493–500, 2013. View at Publisher · View at Google Scholar · View at Scopus
  123. O. S. Dhillon, H. K. Narayan, S. Q. Khan et al., “Pre-discharge risk stratification in unselected STEMI: is there a role for ST2 or its natural ligand IL-33 when compared with contemporary risk markers?” International Journal of Cardiology, vol. 167, no. 5, pp. 2182–2188, 2013. View at Publisher · View at Google Scholar · View at Scopus
  124. M. Rienstra, X. Yin, M. G. Larson et al., “Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin I and incident atrial fibrillation,” The American Heart Journal, vol. 167, no. 1, pp. 109.e2–115.e2, 2014. View at Publisher · View at Google Scholar · View at Scopus
  125. J. E. Ho, S. J. Hwang, K. C. Wollert et al., “Biomarkers of cardiovascular stress and incident chronic kidney disease,” Clinical Chemistry, vol. 59, no. 11, pp. 1613–1620, 2013. View at Publisher · View at Google Scholar · View at Scopus
  126. D. Young, S. Camhi, T. Wu, J. Hagberg, and M. Stefanick, “Relationships among changes in C-reactive protein and cardiovascular disease risk factors with lifestyle interventions,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 23, no. 9, pp. 857–863, 2013. View at Publisher · View at Google Scholar · View at Scopus
  127. H. Mangge, K. Becker, D. Fuchs, and J. M. Gostner, “Antioxidants, inflammation and cardiovascular disease,” World Journal of Cardiology, vol. 6, no. 6, pp. 462–477, 2014. View at Google Scholar
  128. M. Pacurari, R. Kafoury, P. B. Tchounwou, and K. Ndebele, “The renin-angiotensin-aldosterone system in vascular inflammation and remodeling,” International Journal of Inflammation, vol. 2014, Article ID 689360, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  129. M. C. Muñoz, V. Burghi, J. G. Miquet et al., “Downregulation of the ACE2/Ang-(1-7)/Mas axis in transgenic mice overexpressing GH,” Journal of Endocrinology, vol. 221, no. 2, pp. 215–227, 2014. View at Publisher · View at Google Scholar
  130. I. Rachmin, S. Tshori, Y. Smith et al., “Erbin is a negative modulator of cardiac hypertrophy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 16, pp. 5902–5907, 2014. View at Publisher · View at Google Scholar · View at Scopus
  131. T. Takahashi and H. Kubo, “The role of microparticles in chronic obstructive pulmonary disease,” International Journal of Chronic Obstructive Pulmonary Disease, vol. 9, pp. 303–314, 2014. View at Publisher · View at Google Scholar · View at Scopus
  132. L. Hammerova, J. Chabada, J. Drobny, and A. Batorova, “Longitudinal evaluation of markers of hemostasis in pregnancy,” Bratislava Medical Journal, vol. 115, no. 3, pp. 140–144, 2014. View at Publisher · View at Google Scholar · View at Scopus
  133. H. E. Collins, L. He, L. Zou et al., “Stromal interaction molecule 1 is essential for normal cardiac homeostasis through modulation of ER and mitochondrial function,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 306, no. 8, pp. H1231–H1239, 2014. View at Publisher · View at Google Scholar · View at Scopus
  134. V. Xanthakis, M. G. Larson, K. C. Wollert et al., “Association of novel biomarkers of cardiovascular stress with left ventricular hypertrophy and dysfunction: implications for screening,” Journal of the American Heart Association, vol. 2, no. 6, Article ID e000399, 2013. View at Publisher · View at Google Scholar
  135. R. H. Anderson, N. A. Brown, T. J. Mohun, and A. F. Moorman, “Insights from cardiac development relevant to congenital defects and adult clinical anatomy,” Journal of Cardiovascular Translational Research, vol. 6, no. 2, pp. 107–117, 2013. View at Publisher · View at Google Scholar
  136. A. Beiras-Fernandez, F. Weis, J. Rothkopf et al., “Local expression of myocardial galectin-3 does not correlate with its serum levels in patients undergoing heart transplantation,” Annals of Transplantation, vol. 18, no. 1, pp. 643–650, 2013. View at Publisher · View at Google Scholar · View at Scopus
  137. R. L. de la Fuente, P. A. Naesgaard, S. T. Nilsen et al., “Omega-3 index and prognosis in acute coronary chest pain patients with a low dietary intake of omega-3,” Scandinavian Cardiovascular Journal, vol. 47, no. 2, pp. 69–79, 2013. View at Publisher · View at Google Scholar · View at Scopus
  138. E. Thifault, H. Cormier, A. Bouchard-Mercier et al., “Effects of age, sex, body mass index and APOE genotype on cardiovascular biomarker response to an n-3 polyunsaturated fatty acid supplementation,” Journal of Nutrigenetics and Nutrigenomics, vol. 6, no. 2, pp. 73–82, 2013. View at Publisher · View at Google Scholar · View at Scopus
  139. A. M. Fretts, D. Mozaffarian, D. S. Siscovick et al., “Associations of plasma phospholipid and dietary alpha linolenic acid with incident atrial fibrillation in older adults: the Cardiovascular Health Study,” Journal of the American Heart Association, vol. 2, no. 1, Article ID e003814, 2013. View at Publisher · View at Google Scholar · View at Scopus
  140. T. Nicholson, H. Khademi, and M. H. Moghadasian, “The role of marine n-3 fatty acids in improving cardiovascular health: a review,” Food & Function, vol. 4, no. 3, pp. 357–365, 2013. View at Publisher · View at Google Scholar · View at Scopus
  141. A. Nilsson, K. Radeborg, I. Salo, and I. Björck, “Effects of supplementation with n-3 polyunsaturated fatty acids on cognitive performance and cardiometabolic risk markers in healthy 51 to 72 years old subjects: a randomized controlled cross-over study,” Nutrition Journal, vol. 11, article 99, 2012. View at Publisher · View at Google Scholar · View at Scopus
  142. T. C. Baghai, G. Varallo-Bedarida, C. Born et al., “Major depressive disorder is associated with cardiovascular risk factors and low omega-3 index,” Journal of Clinical Psychiatry, vol. 72, no. 9, pp. 1242–1247, 2011. View at Publisher · View at Google Scholar · View at Scopus
  143. M. Ebrahimi, M. Ghayour-Mobarhan, S. Rezaiean et al., “Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity,” Acta cardiologica, vol. 64, no. 3, pp. 321–327, 2009. View at Publisher · View at Google Scholar · View at Scopus
  144. L. V. Wain, “Rare variants and cardiovascular disease,” Briefings in Functional Genomics, vol. 13, no. 5, pp. 384–391, 2014. View at Google Scholar
  145. F. K. Welty, “Hypobetalipoproteinemia and abetalipoproteinemia,” Current Opinion in Lipidology, vol. 25, no. 3, pp. 161–168, 2014. View at Publisher · View at Google Scholar · View at Scopus
  146. L. M. Rice, M. Donigan, M. Yang et al., “Protein phosphatase 2A (PP2A) regulates low density lipoprotein uptake through regulating sterol response element-binding protein-2 (SREBP-2) DNA binding,” The Journal of Biological Chemistry, vol. 289, no. 24, pp. 17268–17279, 2014. View at Publisher · View at Google Scholar
  147. S. Berkinbayev, M. Rysuly, A. Mussayev et al., “Apolipoprotein gene polymorphisms (APOB, APOC111, APOE) in the development of coronary heart disease in ethnic groups of Kazakhstan,” Journal of Genetic Syndromes & Gene Therapy, vol. 5, no. 2, p. 216, 2014. View at Google Scholar
  148. N. Vučinić, I. Djan, E. Stokić et al., “Different associations of apoE gene polymorphism with metabolic syndrome in the Vojvodina Province (Serbia),” Molecular Biology Reports, vol. 41, no. 8, pp. 5221–5227, 2014. View at Publisher · View at Google Scholar · View at Scopus
  149. J. D. Sherrill, K. C. Kiran, C. Blanchard et al., “Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing,” Genes and Immunity, vol. 15, no. 6, pp. 361–369, 2014. View at Publisher · View at Google Scholar
  150. C. Schiano, A. Casamassimi, M. T. Vietri, M. Rienzo, and C. Napoli, “The roles of mediator complex in cardiovascular diseases,” Biochimica et Biophysica Acta—Gene Regulatory Mechanisms, vol. 1839, no. 6, pp. 444–451, 2014. View at Publisher · View at Google Scholar · View at Scopus
  151. S. M. K. Farhan and R. A. Hegele, “Exome sequencing: new insights into lipoprotein disorders,” Current Cardiology Reports, vol. 16, article 507, 2014. View at Publisher · View at Google Scholar · View at Scopus
  152. K. Suhre, “Metabolic profiling in diabetes,” Journal of Endocrinology, vol. 221, no. 3, pp. 75–85, 2014. View at Publisher · View at Google Scholar · View at Scopus
  153. J. A. Kuivenhoven and R. A. Hegele, “Mining the genome for lipid genes,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1842, no. 10, pp. 1993–2009, 2014. View at Publisher · View at Google Scholar
  154. X. Liu, L. Lu, P. Yao et al., “Lipopolysaccharide binding protein, obesity status and incidence of metabolic syndrome: a prospective study among middle-aged and older Chinese,” Diabetologia, vol. 57, no. 9, pp. 1834–1841, 2014. View at Publisher · View at Google Scholar · View at Scopus
  155. N. Nair, S. Gupta, I. X. Collier, E. Gongora, and K. Vijayaraghavan, “Can microRNAs emerge as biomarkers in distinguishing HFpEF versus HFrEF?” International Journal of Cardiology, vol. 175, no. 3, pp. 395–399, 2014. View at Publisher · View at Google Scholar
  156. P. A. Scott, P. A. Townsend, L. L. Ng et al., “Defining potential to benefit from implantable cardioverter defibrillator therapy: the role of biomarkers,” Europace, vol. 13, no. 10, pp. 1419–1427, 2011. View at Publisher · View at Google Scholar · View at Scopus
  157. T. Cebe, P. Atukeren, K. Yanar et al., “Oxidation scrutiny in persuaded aging and chronological aging at systemic redox homeostasis level,” Experimental Gerontology, vol. 57, pp. 132–140, 2014. View at Publisher · View at Google Scholar
  158. M. Kawago, T. Yoshimasu, Y. Tabata et al., “Intrapleural administration of gelatin-embedded, sustained-release basic fibroblast growth factor for the regeneration of emphysematous lungs in rats,” The Journal of Thoracic and Cardiovascular Surgery, vol. 147, no. 5, pp. 1644–1649, 2014. View at Publisher · View at Google Scholar · View at Scopus
  159. P. Tsimaris, E. Deligeoroglou, N. Athanasopoulos et al., “The effect of hormone therapy on biochemical and ultrasound parameters associated with atherosclerosis in 46,XY DSD individuals with female phenotype,” Gynecological Endocrinology, vol. 30, no. 10, pp. 721–725, 2014. View at Publisher · View at Google Scholar
  160. H. Sato, Y. Taketomi, A. Ushida et al., “The adipocyte-inducible secreted phospholipases PLA2G5 and PLA2G2E play distinct roles in obesity,” Cell Metabolism, vol. 20, no. 1, pp. 119–132, 2014. View at Publisher · View at Google Scholar
  161. S. van Veen, D. M. Sørensen, T. Holemans, H. W. Holen, M. G. Palmgren, and P. Vangheluwe, “Cellular function and pathological role of ATP13A2 and related P-type transport ATPases in Parkinson's disease and other neurological disorders,” Frontiers in Molecular Neuroscience, vol. 7, article 48, 2014. View at Publisher · View at Google Scholar · View at Scopus
  162. R. Chowdhury, S. Warnakula, S. Kunutsor et al., “Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis,” Annals of Internal Medicine, vol. 160, no. 9, p. 658, 2014. View at Google Scholar
  163. A. Singhal, J. Lanigan, C. Storry et al., “Docosahexaenoic acid supplementation, vascular function and risk factors for cardiovascular disease: a randomized controlled trial in young adults,” Journal of the American Heart Association, vol. 2, no. 4, article 283, 2013. View at Google Scholar · View at Scopus
  164. C. von Schacky, “The Omega-3 index as a risk factor for cardiovascular diseases,” Prostaglandins and Other Lipid Mediators, vol. 96, no. 1-4, pp. 94–98, 2011. View at Publisher · View at Google Scholar · View at Scopus
  165. F. Mitu, R. Cobzaru, and M. M. Leon, “Influence of metabolic syndrome profile on cardiovascular risk,” Revista Medico-Chirurgicală a Societăţii de Medici şi Naturalişti din Iaşi, vol. 117, no. 2, pp. 308–314, 2013. View at Google Scholar
  166. M. de Vries, B. Klop, and M. Castro Cabezas, “The use of the non-fasting lipid profile for lipid-lowering therapy in clinical practice—point of view,” Atherosclerosis, vol. 234, no. 2, pp. 473–475, 2014. View at Publisher · View at Google Scholar · View at Scopus
  167. L. Li, J. Han, Z. Wang et al., “Mass spectrometry methodology in lipid analysis,” International Journal of Molecular Sciences, vol. 15, no. 6, pp. 10492–10507, 2014. View at Google Scholar
  168. R. Sessa, M. D. Pietro, S. Filardo, and O. Turriziani, “Infectious burden and atherosclerosis: a clinical issue,” World Journal of Clinical Cases, vol. 2, no. 7, pp. 240–249, 2014. View at Google Scholar
  169. L. Rangel-Castilla, M. Y. S. Kalani, J. Russin et al., “108 Cerebral revascularization in the endovascular era: clinical indications, surgical results and outcomes at the barrow neurological institute,” Neurosurgery, vol. 61, p. 194, 2014. View at Publisher · View at Google Scholar
  170. N. Katsiki, D. P. Mikhailidis, and A. S. Wierzbicki, “Epicardial fat and vascular risk: a narrative review,” Current Opinion in Cardiology, vol. 28, no. 4, pp. 458–463, 2013. View at Publisher · View at Google Scholar · View at Scopus
  171. J. I. Weitz, “Insights into the role of thrombin in the pathogenesis of recurrent ischaemia after acute coronary syndrome,” Thrombosis and Haemostasis, vol. 112, no. 5, pp. 924–931, 2014. View at Publisher · View at Google Scholar
  172. V. Naumov, S. Gorokhova, O. Atkov et al., “P324Circadian genes in the regulation of lipids in coronary artery disease,” Cardiovascular Research, vol. 103, supplement 1, pp. S58–S59, 2014. View at Publisher · View at Google Scholar
  173. E. Golia, G. Limongelli, F. Natale et al., “Inflammation and cardiovascular disease: from pathogenesis to therapeutic target,” Current Atherosclerosis Reports, vol. 16, no. 9, p. 435, 2014. View at Publisher · View at Google Scholar
  174. M. McMahon and B. Skaggs, “Pathogenesis and treatment of atherosclerosis in lupus,” Rheumatic Disease Clinics of North America, vol. 40, no. 3, pp. 475–495, 2014. View at Publisher · View at Google Scholar · View at Scopus
  175. I. Martinic-Popovic, A. M. Simundic, L. Dukic et al., “The association of inflammatory markers with cerebral vasoreactivity and carotid atherosclerosis in transient ischaemic attack,” Clinical Biochemistry, vol. 47, no. 16-17, pp. 182–186, 2014. View at Publisher · View at Google Scholar
  176. W. Yu, W. Zha, S. Guo, H. Cheng, J. Wu, and C. Liu, “Flos puerariae extract prevents myocardial apoptosis via attenuation oxidative stress in streptozotocin-induced diabetic mice,” PLoS ONE, vol. 9, no. 5, Article ID e98044, 2014. View at Publisher · View at Google Scholar · View at Scopus
  177. S. V. Arnold, M. Kosiborod, F. Tang et al., “Changes in low-density lipoprotein cholesterol levels after discharge for acute myocardial infarction in a real-world patient population,” American Journal of Epidemiology, vol. 179, no. 11, pp. 1293–1300, 2014. View at Publisher · View at Google Scholar · View at Scopus
  178. A. Kanmanthareddy, A. Vallakati, A. Sridhar et al., “The impact of atrial fibrillation and its treatment on dementia,” Current Cardiology Reports, vol. 16, no. 8, p. 519, 2014. View at Publisher · View at Google Scholar
  179. M. S. Kostapanos and M. S. Elisaf, “High density lipoproteins and type 2 diabetes: emerging concepts in their relationship,” World Journal of Experimental Medicine, vol. 4, no. 1, pp. 1–6, 2014. View at Publisher · View at Google Scholar
  180. C. G. Santos-Gallego and R. S. Rosenson, “Role of HDL in those with diabetes,” Current Cardiology Reports, vol. 16, article 512, 2014. View at Publisher · View at Google Scholar
  181. W. Le Goff, M. Guerin, and M. J. Chapman, “Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia,” Pharmacology & Therapeutics, vol. 101, no. 1, pp. 17–38, 2004. View at Publisher · View at Google Scholar · View at Scopus
  182. H. Jiang, W.-H. Yan, C.-J. Li, A.-P. Wang, J.-T. Dou, and Y.-M. Mu, “Elevated white blood cell count is associated with higher risk of glucose metabolism disorders in middle-aged and elderly Chinese people,” International Journal of Environmental Research and Public Health, vol. 11, no. 5, pp. 5497–5509, 2014. View at Publisher · View at Google Scholar · View at Scopus
  183. K. Nikus, Y. Birnbaum, M. Eskola, S. Sclarovsky, Z. Zhong-Qun, and O. Pahlm, “Updated electrocardiographic classification of acute coronary syndromes,” Current Cardiology Reviews, vol. 10, no. 3, pp. 229–236, 2014. View at Publisher · View at Google Scholar
  184. D. Mozaffarian, P. Shi, J. S. Morris et al., “Mercury exposure and risk of hypertension in US men and women in 2 prospective cohorts,” Hypertension, vol. 60, no. 3, pp. 645–652, 2012. View at Publisher · View at Google Scholar · View at Scopus
  185. J. Yayan, “Emerging families of biomarkers for coronary artery disease: inflammatory mediators,” Vascular Health and Risk Management, vol. 9, no. 1, pp. 435–456, 2013. View at Publisher · View at Google Scholar · View at Scopus
  186. D. C. Chan, P. H. R. Barrett, and G. F. Watts, “The metabolic and pharmacologic bases for treating atherogenic dyslipidaemia,” Best Practice & Research Clinical Endocrinology & Metabolism, vol. 28, no. 3, pp. 369–385, 2014. View at Publisher · View at Google Scholar
  187. S. W. Cho, B. K. Kim, J. H. Kim et al., “Non-invasively measured aortic wave reflection and pulse pressure amplification are related to the severity of coronary artery disease,” Journal of Cardiology, vol. 62, no. 2, pp. 131–137, 2013. View at Publisher · View at Google Scholar · View at Scopus
  188. W. Kloos, B. Vogel, and E. Blessing, “MiRNAs in peripheral artery disease—something gripping this way comes,” Vasa, vol. 43, no. 3, pp. 163–170, 2014. View at Publisher · View at Google Scholar · View at Scopus
  189. Q. A. Truong, J. L. Januzzi, J. Szymonifka et al., “Coronary sinus biomarker sampling compared to peripheral venous blood for predicting outcomes in patients with severe heart failure undergoing cardiac resynchronization therapy: the BIOCRT study,” Heart Rhythm, vol. 11, no. 12, pp. 2167–2175, 2014. View at Publisher · View at Google Scholar
  190. M. M. Joosten, J. K. Pai, M. L. Bertoia et al., “β2-microglobulin, cystatin C, and creatinine and risk of symptomatic peripheral artery disease,” Journal of the American Heart Association, vol. 3, no. 4, Article ID e000803, 2014. View at Publisher · View at Google Scholar
  191. A. Berezin and A. Kremzer, “P194Serum uric acid as independent predictor of decreased number of circulating proangiogenic progenitor cells in asymptomatic coronary artery disease patients,” Cardiovascular Research, vol. 103, supplement 1, p. S34, 2014. View at Publisher · View at Google Scholar
  192. I. E. Dumitriu, P. Baruah, and J. Kaski, “P733Regulatory B cells from patients with coronary artery disease display numerical and functional alterations: a novel immune defect in atherosclerosis,” Cardiovascular Research, vol. 103, supplement 1, pp. S134–S134, 2014. View at Publisher · View at Google Scholar
  193. S. K. Ryu, Z. Mallat, J. Benessiano et al., “Phospholipase A2 enzymes, high-dose atorvastatin, and prediction of ischemic events after acute coronary syndromes,” Circulation, vol. 125, no. 6, pp. 757–766, 2012. View at Publisher · View at Google Scholar
  194. H. C. Kwaan, “From fibrinolysis to the plasminogen-plasmin system and beyond: a remarkable growth of knowledge, with personal observations on the history of fibrinolysis,” Seminars in Thrombosis and Hemostasis, vol. 40, no. 5, pp. 585–591, 2014. View at Publisher · View at Google Scholar
  195. P. Velagapudi, M. K. Turagam, M. A. Leal, and A. G. Kocheril, “Atrial fibrosis: a risk stratifier for atrial fibrillation,” Expert Review of Cardiovascular Therapy, vol. 11, no. 2, pp. 155–160, 2013. View at Publisher · View at Google Scholar · View at Scopus
  196. D. Bryk, W. Olejarz, and D. Zapolska-Downar, “Mitogen-activated protein kinases in atherosclerosis,” Postępy Higieny i Medycyny Doświadczalnej, vol. 68, pp. 10–22, 2014. View at Publisher · View at Google Scholar · View at Scopus
  197. J. Y. Luo, Y. T. Ma, X. Xie et al., “Association of intercellular adhesion molecule1 gene polymorphism with coronary heart disease,” Molecular Medicine Reports, vol. 10, no. 3, pp. 1343–1348, 2014. View at Google Scholar
  198. D. O. McCall, M. C. McKinley, R. Noad et al., “The assessment of vascular function during dietary intervention trials in human subjects,” British Journal of Nutrition, vol. 106, no. 7, pp. 981–994, 2011. View at Publisher · View at Google Scholar · View at Scopus
  199. S. Bhattacharyya, C. Hayward, J. Pepper, and R. Senior, “Risk stratification in asymptomatic severe aortic stenosis: a critical appraisal,” European Heart Journal, vol. 33, no. 19, pp. 2377–2387, 2012. View at Publisher · View at Google Scholar · View at Scopus
  200. R. Chowdhury, S. Warnakula, S. Kunutsor et al., “Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis,” Annals of Internal Medicine, vol. 160, no. 6, pp. 398–406, 2014. View at Google Scholar · View at Scopus
  201. S. N. Shah and J. Arneja, “Efficacy of rosuvastatin in achieving target HDL, LDL, triglycerides and total cholesterol levels in type 2 diabetes mellitus (T2DM) with newly diagnosed dyslipidaemia: an open label, nonrandomised, non-interventional and observational study in India,” Journal of Association of Physicians of India, vol. 61, no. 10, pp. 721–732, 2013. View at Google Scholar · View at Scopus
  202. H. Kato, T. Nakanishi, H. Arai, H. I. Nishida, and T. Nishida, “Purification, microheterogeneity, and stability of human lipid transfer protein,” The Journal of Biological Chemistry, vol. 264, no. 7, pp. 4082–4087, 1989. View at Google Scholar · View at Scopus
  203. J. L. Soulages and M. A. Wells, “Lipophorin: the structure of an insect lipoprotein and its role in lipid transport in insects,” Advances in Protein Chemistry, vol. 45, pp. 371–415, 1994. View at Publisher · View at Google Scholar · View at Scopus
  204. J. F. Oram, “Effects of high density lipoprotein subfractions on cholesterol homeostasis in human fibroblasts and arterial smooth muscle cells,” Arteriosclerosis, vol. 3, no. 5, pp. 420–432, 1983. View at Publisher · View at Google Scholar · View at Scopus
  205. R. K. Ockner and J. A. Manning, “Fatty acid binding protein in small intestine. Identification, isolation, and evidence for its role in cellular fatty acid transport,” The Journal of Clinical Investigation, vol. 54, no. 2, pp. 326–338, 1974. View at Publisher · View at Google Scholar · View at Scopus
  206. R. K. Ockner, J. A. Manning, and J. P. Kane, “Fatty acid binding protein. Isolation from rat liver, characterization, and immunochemical quantification,” The Journal of Biological Chemistry, vol. 257, no. 13, pp. 7872–7878, 1982. View at Google Scholar · View at Scopus
  207. J. H. Veerkamp, R. A. Peeters, and R. G. H. J. Maatman, “Structural and functional features of different types of cytoplasmic fatty acid-binding proteins,” Biochimica et Biophysica Acta, vol. 1081, no. 1, pp. 1–24, 1991. View at Publisher · View at Google Scholar · View at Scopus
  208. J. N. Athanikar and T. F. Osborne, “Specificity in cholesterol regulation of gene expression by coevolution of sterol regulatory DNA element and its binding protein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 9, pp. 4935–4940, 1998. View at Publisher · View at Google Scholar · View at Scopus
  209. A. F. Smith, K. Tsuchida, E. Hanneman, T. C. Suzuki, and M. A. Wells, “Isolation, characterization, and cDNA sequence of two fatty acid-binding proteins from the midgut of Manduca sexta larvae,” The Journal of Biological Chemistry, vol. 267, no. 1, pp. 380–384, 1992. View at Google Scholar · View at Scopus
  210. M. C. van Heusden, D. J. van der Horst, J. M. van Doorn, and A. M. T. Beenakkers, “Partial purification of locust flight muscle lipoprotein lipase (LpL): apparent differences from mammalian LpL,” Comparative Biochemistry and Physiology—Part B: Biochemistry and, vol. 88, no. 2, pp. 523–527, 1987. View at Google Scholar · View at Scopus
  211. A. Stahl, D. J. Hirsch, R. E. Gimeno et al., “Identification of the major intestinal fatty acid transport protein,” Molecular Cell, vol. 4, no. 3, pp. 299–308, 1999. View at Publisher · View at Google Scholar · View at Scopus
  212. G. Nemecz and F. Schroeder, “Selective binding of cholesterol by recombinant fatty acid binding proteins,” The Journal of Biological Chemistry, vol. 266, no. 26, pp. 17180–17186, 1991. View at Google Scholar · View at Scopus
  213. G. V. Richeri, R. T. Ogata, and A. M. Kleinfield, “Equilibrium constants for the binding of fatty acids with fatty acid-binding proteins from adipocyte, intestine, heart, and liver measured with the fluorescent probe ADIFAB,” The Journal of Biological Chemistry, vol. 269, pp. 23918–23930, 1994. View at Google Scholar
  214. N. H. Haunerland and J. M. Chisholm, “Fatty acid binding protein in flight muscle of the locus, Schistocerca gregaria,” Biochimica et Biophysica Acta, vol. 1047, no. 3, pp. 233–238, 1990. View at Publisher · View at Google Scholar · View at Scopus
  215. J. Ayala-Sanmartin, “Cholesterol enhances phospholipid binding and aggregation of annexins by their core domain,” Biochemical and Biophysical Research Communications, vol. 283, no. 1, pp. 72–79, 2001. View at Publisher · View at Google Scholar · View at Scopus
  216. P. G. Pentchev, R. O. Brady, E. J. Blanchette-Mackie et al., “The Niemann-Pick C lesion and its relationship to the intracellular distribution and utilization of LDL cholesterol,” Biochimica et Biophysica Acta, vol. 1225, no. 3, pp. 235–243, 1994. View at Publisher · View at Google Scholar · View at Scopus
  217. X.-X. Xu and I. Tabas, “Lipoproteins activate acyl-coenzyme A: cholesterol acyltransferase in macrophages only after cellular cholesterol pools are expanded to a critical threshold level,” Journal of Biological Chemistry, vol. 266, no. 26, pp. 17040–17048, 1991. View at Google Scholar · View at Scopus
  218. S.-O. Olofsson, L. Asp, and J. Borén, “The assembly and secretion of apolipoprotein B-containing lipoproteins,” Current Opinion in Lipidology, vol. 10, no. 4, pp. 341–346, 1999. View at Publisher · View at Google Scholar · View at Scopus
  219. T. Y. Chang, C. C. Y. Chang, and D. Cheng, “Acyl-coenzyme A: cholesterol acyltransferase,” Annual Review of Biochemistry, vol. 66, pp. 613–638, 1997. View at Publisher · View at Google Scholar · View at Scopus
  220. D. A. Chappell, G. L. Fry, M. A. Waknitz, and J. J. Berns, “Ligand size as a determinant for catabolism by the low density lipoprotein (LDL) receptor pathway,” The Journal of Biological Chemistry, vol. 266, no. 29, pp. 19296–19302, 1991. View at Google Scholar · View at Scopus
  221. Y. Lange, J. Ye, M. Rigney, and T. Steck, “Cholesterol movement in Niemann-Pick type C cells and in cells treated with amphiphiles,” Journal of Biological Chemistry, vol. 275, no. 23, pp. 17468–17475, 2000. View at Publisher · View at Google Scholar · View at Scopus
  222. J. Merino, L. Masana, C. Guijarro, J. Ascaso, M. Lagares, and F. Civeira, “Recomendations for clinical use of food enriched phytosterols/phytostanols handling hypercholesterolemia,” Clínica e Investigación en Arteriosclerosis, vol. 26, no. 3, pp. 147–158, 2014. View at Publisher · View at Google Scholar · View at Scopus
  223. N. Greyshock, J. R. Guyton, S. Sebastian, and D. Okorodudu, “APOE p.Leu167del-related lipid disorders,” in GeneReviews, R. A. Pagon, M. P. Adam, H. H. Ardinger et al., Eds., University of Washington, Seattle, Wash, USA, 1993–2014. View at Google Scholar
  224. E. K. Hoogeveen, J. M. Geleijnse, D. Kromhout et al., “No effect of n-3 fatty acids supplementation on NT-proBNP after myocardial infarction: The Alpha Omega Trial,” European Journal of Preventive Cardiology, 2014. View at Publisher · View at Google Scholar
  225. D. K. Strickland, D. T. Au, P. Cunfer, and S. C. Muratoglu, “Low-density lipoprotein receptor-related protein-1: role in the regulation of vascular integrity,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 3, pp. 487–498, 2014. View at Publisher · View at Google Scholar · View at Scopus
  226. S. Hirayama and T. Miida, “Small dense LDL: an emerging risk factor for cardiovascular disease,” Clinica Chimica Acta, vol. 414, pp. 215–224, 2012. View at Publisher · View at Google Scholar · View at Scopus
  227. X.-X. Xu and I. Tabas, “Lipoproteins activate acyl-coenzyme A:cholesterol acyl transferase in macrophages only after cellular cholesterol pools are expanded to a critical threshold level,” Journal of Biological Chemistry, vol. 266, no. 26, pp. 17040–17048, 1991. View at Google Scholar · View at Scopus
  228. E. Ikonen, “Cellular cholesterol trafficking and compartmentalization,” Nature Reviews Molecular Cell Biology, vol. 9, no. 2, pp. 125–138, 2008. View at Publisher · View at Google Scholar · View at Scopus
  229. S. D. Clarke and M. K. Armstrong, “Cellular lipid binding proteins: expression, function, and nutritional regulation,” The FASEB Journal, vol. 3, no. 13, pp. 2480–2487, 1989. View at Google Scholar · View at Scopus
  230. C. E. Kosmas, G. Christodoulidis, J.-W. Cheng, T. J. Vittorio, and S. Lerakis, “High-density lipoprotein functionality in coronary artery disease,” The American Journal of the Medical Sciences, vol. 347, no. 6, pp. 504–508, 2014. View at Publisher · View at Google Scholar · View at Scopus
  231. A. Sniderman and P. O. Kwiterovich, “Update on the detection and treatment of atherogenic low-density lipoproteins,” Current Opinion in Endocrinology, Diabetes and Obesity, vol. 20, no. 2, pp. 140–147, 2013. View at Publisher · View at Google Scholar · View at Scopus
  232. V. Ramjee, L. S. Sperling, and T. A. Jacobson, “Non-high-density lipoprotein cholesterol versus apolipoprotein B in cardiovascular risk stratification: do the math,” Journal of the American College of Cardiology, vol. 58, no. 5, pp. 457–463, 2011. View at Publisher · View at Google Scholar · View at Scopus
  233. M. de Vries, B. Klop, and M. C. Cabezas, “The use of the non-fasting lipid profile for lipid-lowering therapy in clinical practice—point of view,” Atherosclerosis, vol. 234, no. 2, pp. 473–475, 2014. View at Publisher · View at Google Scholar · View at Scopus
  234. R. Koldamova, N. F. Fitz, and I. Lefterov, “ATP-binding cassette transporter A1: from metabolism to neurodegeneration,” Neurobiology of Disease, vol. 72, pp. 13–21, 2014. View at Publisher · View at Google Scholar
  235. L. A. Stechschulte Jr., T. D. Hinds, S. S. Khuder, W. Shou, S. M. Najjar, and E. R. Sanchez, “FKBP51 controls cellular adipogenesis through p38 kinase-mediated phosphorylation of GRα and PPARγ,” Molecular Endocrinology, vol. 28, no. 8, pp. 1265–1275, 2014. View at Publisher · View at Google Scholar
  236. C.-L. Wu, S.-P. Zhao, and B.-L. Yu, “Intracellular role of exchangeable apolipoproteins in energy homeostasis, obesity and non-alcoholic fatty liver disease,” Biological reviews of the Cambridge Philosophical Society, 2014. View at Publisher · View at Google Scholar
  237. M. Kwong and K. M. Wasan, “Cholesteryl ester transfer protein facilitates the movement of water-insoluble drugs between lipoproteins: a novel biological function for a well-characterized lipid transfer protein,” Biochemical Pharmacology, vol. 64, no. 12, pp. 1669–1675, 2002. View at Publisher · View at Google Scholar · View at Scopus
  238. R. Rao, J. J. Albers, G. Wolfbauer, and H. J. Pownall, “Molecular and macromolecular specificity of human plasma phospholipid transfer protein,” Biochemistry, vol. 36, no. 12, pp. 3645–3653, 1997. View at Publisher · View at Google Scholar · View at Scopus
  239. T. Ohnishi, K. Oikawa, C. M. Kay, and S. Yokoyama, “Modulation of substrate selectivity in plasma lipid transfer protein reaction over structural variation of lipid particle,” Biochimica et Biophysica Acta, vol. 1254, no. 2, pp. 117–126, 1995. View at Publisher · View at Google Scholar · View at Scopus
  240. T. Ohnishi, C. Tan, and S. Yokoyama, “Selective transfer of cholesteryl ester over triglyceride by human plasma lipid transfer protein between apolipoprotein-activated lipid microemulsions,” Biochemistry, vol. 33, no. 15, pp. 4533–4542, 1994. View at Publisher · View at Google Scholar · View at Scopus
  241. H. I. Nishida, H. Arai, and T. Nishida, “Cholesterol ester transfer mediated by lipid transfer protein as influenced by changes in the charge characteristics of plasma lipoproteins,” The Journal of Biological Chemistry, vol. 268, no. 22, pp. 16352–16360, 1993. View at Google Scholar · View at Scopus
  242. T. Ohnishi and S. Yokoyama, “Activation of human plasma lipid transfer protein by apolipoproteins,” Biochemistry, vol. 32, no. 19, pp. 5029–5035, 1993. View at Publisher · View at Google Scholar · View at Scopus
  243. R. O. Ryan, S. Yokoyama, H. Liu, H. Czarnecka, K. Oikawa, and C. M. Kay, “Human apolipoprotein A-I liberated from high-density lipoprotein without denaturation,” Biochemistry, vol. 31, no. 18, pp. 4509–4514, 1992. View at Publisher · View at Google Scholar · View at Scopus
  244. T. Ohnishi, K. Oikawa, C. M. Kay, and S. Yokoyama, “Modulation of substrate selectivity in plasma lipid transfer protein reaction over structural variation of lipid particle,” Biochimica et Biophysica Acta—Lipids and Lipid Metabolism, vol. 1254, no. 2, pp. 117–126, 1995. View at Publisher · View at Google Scholar · View at Scopus
  245. E. T. Silver, D. G. Scraba, and R. O. Ryan, “Lipid transfer particle-induced transformation of human high density lipoprotein into apolipoprotein A-I-deficient low density particles,” The Journal of Biological Chemistry, vol. 265, no. 36, pp. 22487–22492, 1990. View at Google Scholar · View at Scopus
  246. R. E. Morton, “Interaction of lipid transfer protein with plasma lipoproteins and cell membranes,” Experientia, vol. 46, no. 6, pp. 552–560, 1990. View at Publisher · View at Google Scholar · View at Scopus
  247. R. E. Morton and J. V. Steinbrunner, “Concentration of neutral lipids in the phospholipid surface of substrate particles determines lipid transfer protein activity,” Journal of Lipid Research, vol. 31, no. 9, pp. 1559–1567, 1990. View at Google Scholar · View at Scopus
  248. J. E. M. Groener, T. van Gent, and A. van Tol, “Effect of lipid transfer protein on plasma lipids, apolipoproteins and metabolism of high-density lipoprotein cholesteryl ester in the rat,” Biochimica et Biophysica Acta, vol. 1002, no. 1, pp. 93–100, 1989. View at Publisher · View at Google Scholar · View at Scopus
  249. T. Nishide, J. H. Tollefson, and J. J. Albers, “Inhibition of lipid transfer by a unique high density lipoprotein subclass containing an inhibitor protein,” Journal of Lipid Research, vol. 30, no. 2, pp. 149–158, 1989. View at Google Scholar · View at Scopus
  250. R. E. Morton, “Free cholesterol is a potent regulatore of lipid transfer protein function,” The Journal of Biological Chemistry, vol. 263, no. 25, pp. 12235–12241, 1988. View at Google Scholar · View at Scopus
  251. M. Abbey, S. Bastiras, and G. D. Calvert, “Immunoprecipitation of lipid transfer protein activity by an antibody against human plasma lipid transfer protein-I,” Biochimica et Biophysica Acta—Lipids and Lipid Metabolism, vol. 833, no. 1, pp. 25–33, 1985. View at Publisher · View at Google Scholar · View at Scopus
  252. D. D. Sviridov, A. Y. Misharin, I. G. Safonova, N. G. Bushmakina, V. S. Repin, and V. N. Smirnov, “Binding of partially reassembled high-density lipoprotein to isolated human small intestine epithelial cells. Effect of lipid composition,” Biochimica et Biophysica Acta, vol. 963, pp. 119–125, 1988. View at Publisher · View at Google Scholar
  253. D. J. van der Horst, P. Stoppie, R. Huybrechts, A. de Loof, and A. M. T. Beenakkers, “Immunological relationships between the diacylglycerol-transporting lipoproteins in the haemolymph of Locusta,” Comparative Biochemistry and Physiology, vol. 70, no. 3, pp. 387–392, 1981. View at Google Scholar · View at Scopus
  254. D. J. van der Horst, J. M. van Doorn, A. N. de Keijzer, and A. M. T. Beenakkers, “Interconversions of diacylglycerol-transporting lipoproteins in the haemolymph of Locusta migratoria,” Insect Biochemistry, vol. 11, no. 6, pp. 717–723, 1981. View at Publisher · View at Google Scholar · View at Scopus
  255. M. A. Wells, R. O. Ryan, J. K. Kawooya, and J. H. Law, “The role of apolipophorin III in in vivo lipoprotein interconversions in adult Manduca sexta,” The Journal of Biological Chemistry, vol. 262, no. 9, pp. 4172–4176, 1987. View at Google Scholar · View at Scopus
  256. T. K. A. Singh and R. O. Ryan, “Lipid transfer particle-catalyzed transfer of lipoprotein-associated diacylglycerol and long chain aliphatic hydrocarbons,” Archives of Biochemistry and Biophysics, vol. 286, no. 2, pp. 376–382, 1991. View at Publisher · View at Google Scholar · View at Scopus
  257. E. G. Sukhorukova, S. A. Bekoeva, V. F. Korzhevskaia, A. F. Tsukanova, and D. É. Korzhevskiǐ, “Diagnostic potential of the histochemical methods used in histological studies of the heart,” Sudebno-Meditsinskaia Ekspertiza, vol. 56, no. 4, pp. 38–40, 2013. View at Google Scholar · View at Scopus
  258. R. M. Mayer, C. R. Treadwell, L. L. Gallo, and G. V. Vahouny, “Intestinal mucins and cholesterol uptake in vitro,” Biochimica et Biophysica Acta, vol. 833, no. 1, pp. 34–43, 1985. View at Publisher · View at Google Scholar · View at Scopus
  259. C. Haruo, R. G. H. Downer, and T. Koui, “The role of diacylglycerol-carrying lipoprotein I in lipid transport during insect vitellogenesis,” Biochimica et Biophysica Acta—Lipids and Lipid Metabolism, vol. 487, no. 3, pp. 508–516, 1977. View at Publisher · View at Google Scholar · View at Scopus
  260. J. Klucken, C. Büchler, E. Orsó et al., “ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 2, pp. 817–822, 2000. View at Publisher · View at Google Scholar · View at Scopus
  261. R. K. Upadhyay, H. C. Agarwal, and R. Dhar, “Protein mediated cholesterol absorption in locusts Schistocerca gregaria (Forskal) and Locusta migratoria (Linn),” Indian Journal of Experimental Biology, vol. 40, no. 2, pp. 151–161, 2002. View at Google Scholar · View at Scopus
  262. H. K. Yun, Z. E. Jouni, and M. A. Wells, “Characterization of cholesterol transport from midgut to fat body in Manduca sexta larvae,” Insect Biochemistry and Molecular Biology, vol. 32, no. 9, pp. 1151–1158, 2002. View at Publisher · View at Google Scholar · View at Scopus
  263. G. V. Vahouny, R. Chanderbhan, P. Stewart et al., “Phospholipids, sterol carrier protein 2 and adrenal steroidogenesis,” Biochimica et Biophysica Acta, vol. 834, no. 3, pp. 324–330, 1985. View at Publisher · View at Google Scholar · View at Scopus
  264. S.-P. Tam, L. Mok, G. Chimini, M. Vasa, and R. G. Deeley, “ABCA1 mediates high-affinity uptake of 25-hydroxycholesterol by membrane vesicles and rapid efflux of oxysterol by intact cells,” The American Journal of Physiology—Cell Physiology, vol. 291, no. 3, pp. C490–C502, 2006. View at Publisher · View at Google Scholar · View at Scopus
  265. A. Radhakrishnan, L.-P. Sun, H. J. Kwon, M. S. Brown, and J. L. Goldstein, “Direct binding of cholesterol to the purified membrane region of SCAP: mechanism for a sterol-sensing domain,” Molecular Cell, vol. 15, no. 2, pp. 259–268, 2004. View at Publisher · View at Google Scholar · View at Scopus
  266. J. Wang, F. Sun, D.-W. Zhang et al., “Sterol transfer by ABCG5 and ABCG8: in vitro assay and reconstitution,” The Journal of Biological Chemistry, vol. 281, no. 38, pp. 27894–27904, 2006. View at Publisher · View at Google Scholar · View at Scopus
  267. N. M. Bass, “The cellular fatty acid binding proteins: aspects of structure, regulation, and function,” International Review of Cytology, vol. 111, pp. 143–184, 1988. View at Publisher · View at Google Scholar · View at Scopus
  268. M. S. Brown and J. L. Goldstein, “A receptor-mediated pathway for cholesterol homeostasis,” Science, vol. 232, no. 4746, pp. 34–47, 1986. View at Publisher · View at Google Scholar · View at Scopus
  269. S. Mitsos, E. N. Koletsis, K. Katsanos et al., “Intramyocardial thrombin promotes angiogenesis and improves cardiac function in an experimental rabbit model of acute myocardial infarction,” Journal of Thoracic and Cardiovascular Surgery, vol. 147, no. 4, pp. 1376–1383, 2014. View at Publisher · View at Google Scholar · View at Scopus
  270. F. J. Steyers and C. M. Miller, “Endothelial dysfunction in chronic inflammatory diseases,” International Journal of Molecular Sciences, vol. 15, no. 7, pp. 11324–11349, 2014. View at Publisher · View at Google Scholar
  271. T. P. Zheng, F. Yang, Y. Gao et al., “Increased plasma DPP4 activities predict new-onset atherosclerosis in association with its proinflammatory effects in Chinese over a four year period: a prospective study,” Atherosclerosis, vol. 235, no. 2, pp. 619–624, 2014. View at Publisher · View at Google Scholar
  272. K. Yin and D. K. Agrawal, “Vitamin D and inflammatory diseases,” Journal of Inflammation Research, vol. 7, no. 1, pp. 69–87, 2014. View at Publisher · View at Google Scholar · View at Scopus
  273. Y. B. Joshi and D. Praticò, “Lipid peroxidation in psychiatric illness: overview of clinical evidence,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 828702, 5 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  274. R. B. Schnabel, M. Seiffert, S. Wilde et al., “Kidney injury and mortality after transcatheter aortic valve implantation in a routine clinical cohort,” Catheterization and Cardiovascular Interventions, vol. 85, no. 3, pp. 440–447, 2015. View at Publisher · View at Google Scholar
  275. G. Grassia, N. MacRitchie, A. M. Platt, J. M. Brewer, P. Garside, and P. Maffia, “Plasmacytoid dendritic cells: biomarkers or potential therapeutic targets in atherosclerosis?” Pharmacology & Therapeutics, vol. 137, no. 2, pp. 172–182, 2013. View at Publisher · View at Google Scholar · View at Scopus
  276. K. T. Lappegård, P. Garred, L. Jonasson et al., “A vital role for complement in heart disease,” Molecular Immunology, vol. 61, no. 2, pp. 126–134, 2014. View at Publisher · View at Google Scholar
  277. J. N. Fullerton, A. J. O'Brien, and D. W. Gilroy, “Pathways mediating resolution of inflammation: when enough is too much,” Journal of Pathology, vol. 231, no. 1, pp. 8–20, 2013. View at Publisher · View at Google Scholar · View at Scopus
  278. L. T. Weckbach, A. Gola, M. Winkelmann et al., “The cytokine midkine supports neutrophil trafficking during acute inflammation by promoting adhesion via β2 integrins (CD11/CD18),” Blood, vol. 123, no. 12, pp. 1887–1896, 2014. View at Publisher · View at Google Scholar · View at Scopus
  279. H. Martynowicz, A. Janus, D. Nowacki, and G. Mazur, “The role of chemokines in hypertension,” Advances in Clinical and Experimental Medicine, vol. 23, no. 3, pp. 319–325, 2014. View at Publisher · View at Google Scholar
  280. W. M. Al-Ghoul, M. S. Kim, N. Fazal, A. C. Azim, and A. Ali, “Evidence for simvastatin anti-inflammatory actions based on quantitative analyses of NETosis and other inflammation/oxidation markers,” Results in Immunology, vol. 4, no. 1, pp. 14–22, 2014. View at Publisher · View at Google Scholar · View at Scopus
  281. K. R. de Andrade, G. R. W. de Castro, G. Vicente et al., “Evaluation of circulating levels of inflammatory and bone formation markers in axial spondyloarthritis,” International Immunopharmacology, vol. 21, no. 2, pp. 481–486, 2014. View at Publisher · View at Google Scholar
  282. H. Swede, A. M. Hajduk, J. Sharma et al., “Baseline serum C-reactive protein and death from colorectal cancer in the NHANES III cohort,” International Journal of Cancer, vol. 134, no. 8, pp. 1862–1870, 2014. View at Publisher · View at Google Scholar · View at Scopus
  283. S. Kaptoge, E. di Angelantonio, L. Pennells, A. M. Wood, I. R. White, and P. Gao, “C-reactive protein, fibrinogen, and cardiovascular disease prediction,” The New England Journal of Medicine, vol. 367, no. 14, pp. 1310–1320, 2012. View at Google Scholar
  284. P. Ferroni, S. Riondino, N. Vazzana, N. Santoro, F. Guadagni, and G. Davì, “Biomarkers of platelet activation in acute coronary syndromes,” Thrombosis and Haemostasis, vol. 108, no. 6, pp. 1109–1123, 2012. View at Publisher · View at Google Scholar · View at Scopus
  285. J. Jantsch, K. J. Binger, D. N. Müller, and J. Titze, “Macrophages in homeostatic immune function,” Frontiers in Physiology, vol. 5, p. 146, 2014. View at Publisher · View at Google Scholar
  286. V. V. Voǐtsekhovskis, I. G. Voǐtsekhovska, A. Shkesters et al., “Advances of selenium supplementation in posttraumatic stress disorder risk group patients,” Biomeditsinskaia Khimiia, vol. 60, no. 1, pp. 125–132, 2014. View at Google Scholar · View at Scopus
  287. P. Kreis, G. Leondaritis, I. Lieberam, and B. J. Eickholt, “Subcellular targeting and dynamic regulation of PTEN: implications for neuronal cells and neurological disorders,” Frontiers in Molecular Neuroscience, vol. 7, no. 1, article 23, 2014. View at Publisher · View at Google Scholar · View at Scopus
  288. B. D. Korman, C.-C. Huang, C. Skamra et al., “Inflammatory expression profiles in monocyte to macrophage differentiation in patients with systemic lupus erythematosus and relationship with atherosclerosis,” Arthritis Research & Therapy, vol. 16, no. 4, p. R147, 2014. View at Publisher · View at Google Scholar
  289. L. Q. Chen, J. A. de Lemos, S. R. Das, C. R. Ayers, and A. Rohatgi, “Soluble ST2 is associated with all-cause and cardiovascular mortality in a population-based cohort: the dallas heart study,” Clinical Chemistry, vol. 59, no. 3, pp. 536–546, 2013. View at Publisher · View at Google Scholar · View at Scopus
  290. K. B. Shah, W. J. Kop, R. H. Christenson et al., “Prognostic utility of ST2 in patients with acute dyspnea and preserved left ventricular ejection fraction,” Clinical Chemistry, vol. 57, no. 6, pp. 874–882, 2011. View at Publisher · View at Google Scholar · View at Scopus
  291. B. Ky, B. French, K. McCloskey et al., “High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure,” Circulation: Heart Failure, vol. 4, no. 2, pp. 180–187, 2011. View at Publisher · View at Google Scholar · View at Scopus
  292. G. M. Felker, M. Fiuzat, V. Thompson et al., “Soluble ST2 in ambulatory patients with heart failure: association with functional capacity and long-term outcomes,” Circulation: Heart Failure, vol. 6, no. 6, pp. 1172–1179, 2013. View at Publisher · View at Google Scholar · View at Scopus
  293. A. Bayes-Genis, M. de Antonio, J. Vila et al., “Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3,” Journal of the American College of Cardiology, vol. 63, no. 2, pp. 158–166, 2014. View at Publisher · View at Google Scholar · View at Scopus
  294. B. Dieplinger, M. Egger, M. Haltmayer et al., “Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease: results from the Ludwigshafen risk and cardiovascular health study,” Clinical Chemistry, vol. 60, no. 3, pp. 530–540, 2014. View at Publisher · View at Google Scholar
  295. P. Kohli, M. P. Bonaca, R. Kakkar et al., “Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial,” Clinical Chemistry, vol. 58, no. 1, pp. 257–266, 2012. View at Publisher · View at Google Scholar · View at Scopus
  296. T. J. Wang, K. C. Wollert, M. G. Larson et al., “Prognostic utility of novel biomarkers of cardiovascular stress: the framingham heart study,” Circulation, vol. 126, no. 13, pp. 1596–1604, 2012. View at Publisher · View at Google Scholar · View at Scopus
  297. D. H. Fitchett, G. B. J. Mancini, J. Gregoire, T. Anderson, and R. McPherson, “Risk stratification and selection for statin therapy: going beyond framingham,” Canadian Journal of Cardiology, vol. 30, no. 6, pp. 667–670, 2014. View at Publisher · View at Google Scholar · View at Scopus
  298. M. Habibi, H. Chahal, A. Opdahl et al., “Association of CMR-measured LA function with heart failure development: results from the MESA Study,” JACC: Cardiovascular Imaging, vol. 7, no. 6, pp. 570–579, 2014. View at Publisher · View at Google Scholar · View at Scopus
  299. R. Panovsky, M. Pleva, V. Feitova, P. Kruzliak, J. Meluzin, and V. Kincl, “The prognostic impact of myocardial late gadolinium enhancement,” Cardiology in Review, vol. 22, no. 3, pp. 128–139, 2014. View at Publisher · View at Google Scholar · View at Scopus
  300. C. M. Ferrario and W. B. Strawn, “Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease,” The American Journal of Cardiology, vol. 98, no. 1, pp. 121–128, 2006. View at Publisher · View at Google Scholar · View at Scopus
  301. S. Raut, M. Hamill, S. Daniels, A. B. Heath, and The Subcommittee on Factor XIII/Fibrinogen, “Value assignment to the WHO 3rd International Standard for Blood Coagulation Fibrinogen Plasma (09/264): communication from the SSC of the ISTH,” Journal of Thrombosis and Haemostasis, vol. 12, no. 10, pp. 1754–1757, 2014. View at Publisher · View at Google Scholar
  302. S. Raut, M. Hamill, S. Daniels, and A. B. Heath, “Value assignment to the WHO 3rd International Standard for Blood Coagulation Fibrinogen Plasma (09/264): communication from the SSC of the ISTH,” Journal of Thrombosis and Haemostasis, vol. 12, no. 10, pp. 1754–1757, 2014. View at Publisher · View at Google Scholar
  303. N. Zsíros, G. Paragh, and M. Harangi, “Clinical significance and treatment options of increased lipoprotein(a),” Orvosi Hetilap, vol. 155, no. 16, pp. 607–614, 2014. View at Publisher · View at Google Scholar · View at Scopus
  304. D. Santoro, G. Gagliostro, A. Alibrandi et al., “Vitamin D receptor gene polymorphism and left ventricular hypertrophy in chronic kidney disease,” Nutrients, vol. 6, no. 3, pp. 1029–1037, 2014. View at Publisher · View at Google Scholar
  305. P. Tornhammar, P. Ueda, M. Hult, H. Simila, D. Eyles, and M. Norman, “Season of birth, neonatal vitamin D status, and cardiovascular disease risk at 35 y of age: a cohort study from Sweden,” American Journal of Clinical Nutrition, vol. 99, no. 3, pp. 472–478, 2014. View at Publisher · View at Google Scholar · View at Scopus
  306. D. M. Hirai, S. W. Copp, C. T. Holdsworth et al., “Skeletal muscle microvascular oxygenation dynamics in heart failure: exercise training and nitric oxide-mediated function,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 306, no. 5, pp. H690–H698, 2014. View at Publisher · View at Google Scholar · View at Scopus
  307. K. Matsuoka, Y. Asano, S. Higo et al., “Noninvasive and quantitative live imaging reveals a potential stress-responsive enhancer in the failing heart,” The FASEB Journal, vol. 28, no. 4, pp. 1870–1879, 2014. View at Publisher · View at Google Scholar · View at Scopus
  308. R. Hurford, A. Charidimou, Z. Fox, L. Cipolotti, R. Jager, and D. J. Werring, “MRI-visible perivascular spaces: relationship to cognition and small vessel disease MRI markers in ischaemic stroke and TIA,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 85, no. 5, pp. 522–525, 2014. View at Publisher · View at Google Scholar · View at Scopus
  309. R. Hurford, A. Charidimou, Z. Fox, L. Cipolotti, R. Jager, and D. J. Werring, “MRI-visible perivascular spaces: Relationship to cognition and small vessel disease MRI markers in ischaemic stroke and TIA,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 85, no. 5, pp. 522–525, 2014. View at Publisher · View at Google Scholar · View at Scopus
  310. J. Clària, B. T. Nguyen, A. L. Madenci, C. K. Ozaki, and C. N. Serhan, “Diversity of lipid mediators in human adipose tissue depots,” The American Journal of Physiology—Cell Physiology, vol. 304, no. 12, pp. C1141–C1149, 2013. View at Publisher · View at Google Scholar · View at Scopus
  311. S. Moylan, M. Berk, O. M. Dean et al., “Oxidative & nitrosative stress in depression: why so much stress?” Neuroscience and Biobehavioral Reviews, vol. 45, pp. 46–62, 2014. View at Publisher · View at Google Scholar · View at Scopus
  312. C. Lipina, A. J. Irving, and H. S. Hundal, “Mitochondria: a possible nexus for the regulation of energy homeostasis by the endocannabinoid system,” American Physiological Society—Endocrinology and Metabolism, vol. 307, no. 1, pp. E1–E13, 2014. View at Publisher · View at Google Scholar
  313. C. Dawczynski, K. A. Massey, C. Ness et al., “Randomized placebo-controlled intervention with n-3 LC-PUFA-supplemented yoghurt: effects on circulating eicosanoids and cardiovascular risk factors,” Clinical Nutrition, vol. 32, no. 5, pp. 686–696, 2013. View at Publisher · View at Google Scholar · View at Scopus
  314. H. Wu, E. L. Ding, E. T. Toledo et al., “A novel fatty acid lipophilic index and risk of CHD in US men: the Health Professionals Follow-Up Study,” British Journal of Nutrition, vol. 110, no. 3, pp. 466–474, 2013. View at Publisher · View at Google Scholar · View at Scopus
  315. A. C. Salisbury, A. P. Amin, W. S. Harris et al., “Predictors of omega-3 index in patients with acute myocardial infarction,” Mayo Clinic Proceedings, vol. 86, no. 7, pp. 626–632, 2011. View at Publisher · View at Google Scholar · View at Scopus
  316. A. Sala-Vila, W. S. Harris, M. Cofán et al., “Determinants of the omega-3 index in a Mediterranean population at increased risk for CHD,” British Journal of Nutrition, vol. 106, no. 3, pp. 425–431, 2011. View at Publisher · View at Google Scholar · View at Scopus
  317. W. S. Harris, “The omega-3 index: from biomarker to risk marker to risk factor,” Current Atherosclerosis Reports, vol. 11, no. 6, pp. 411–417, 2009. View at Publisher · View at Google Scholar · View at Scopus
  318. I. Birlouez-Aragon, G. Saavedra, F. J. Tessier et al., “A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases,” The American Journal of Clinical Nutrition, vol. 91, no. 5, pp. 1220–1226, 2010. View at Publisher · View at Google Scholar · View at Scopus
  319. S. Caspar-Bauguila, J. Garcia, A. Galiniera et al., “Positive impact of long-term lifestyle change on erythrocyte fatty acid profile after acute coronary syndromes,” Archives of Cardiovascular Diseases, vol. 103, no. 2, pp. 106–114, 2010. View at Publisher · View at Google Scholar · View at Scopus
  320. G. F. Ming, X. Li, J. Y. Yin et al., “JAZF1 regulates visfatin expression in adipocytes via PPARα and PPARβ/δ signaling,” Metabolism, vol. 63, no. 8, pp. 1012–1021, 2014. View at Publisher · View at Google Scholar
  321. G. Koutsis, G. Siasos, and K. Spengos, “The emerging role of microRNA in stroke,” Current Topics in Medicinal Chemistry, vol. 13, no. 13, pp. 1573–1588, 2013. View at Publisher · View at Google Scholar · View at Scopus
  322. M. Mirbolouk, S. Asgari, F. Sheikholeslami, F. Mirbolouk, F. Azizi, and F. Hadaegh, “Different obesity phenotypes, and incident cardiovascular disease and mortality events in elderly iranians: Tehran lipid and glucose study,” Geriatrics and Gerontology International, 2014. View at Publisher · View at Google Scholar · View at Scopus
  323. S. Mavrogeni, P. Sfikakis, T. Dimitroulas, G. Kolovou, and G. Kitas, “Cardiac and muscular involvement in idiopathic inflammatory myopathies: noninvasive diagnostic assessment and the role of cardiovascular and skeletal magnetic resonance imaging,” Inflammation & Allergy-Drug Targets, vol. 13, no. 3, pp. 206–216, 2014. View at Publisher · View at Google Scholar
  324. D. Abdurrachim, J. Ciapaite, B. Wessels et al., “Cardiac diastolic dysfunction in high-fat diet fed mice is associated with lipotoxicity without impairment of cardiac energetics in vivo,” Biochimica et Biophysica Acta, vol. 1841, no. 10, pp. 1525–1537, 2014. View at Publisher · View at Google Scholar
  325. T. Yorozu, “Prevention of venous thromboembolism and anticoagulant therapy,” Japanese Journal of Anesthesiology, vol. 63, no. 3, pp. 278–286, 2014. View at Google Scholar · View at Scopus
  326. R. Mahmoudizad, A. Samrao, J. J. Bentow, S.-K. Peng, and N. Bhatia, “Composite hemangioendothelioma: an unusual presentation of a rare vascular tumor,” American Journal of Clinical Pathology, vol. 141, no. 5, pp. 732–736, 2014. View at Publisher · View at Google Scholar
  327. J. R. Romero, S. R. Preis, A. Beiser et al., “Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the framingham heart study,” Stroke, vol. 45, no. 5, pp. 1492–1494, 2014. View at Publisher · View at Google Scholar · View at Scopus
  328. R. Goel, T. S. Kumar, D. Danda et al., “Childhood-onset Takayasu arteritis—experience from a tertiary care center in south India,” Journal of Rheumatology, vol. 41, no. 6, pp. 1183–1189, 2014. View at Publisher · View at Google Scholar · View at Scopus
  329. I. B. Riaz, A. Singh, and R. Janardhanan, “Chest pain and elevated troponins in a patient with prior coronary artery disease: a diagnostic dilemma,” The American Journal of Medicine, vol. 127, no. 6, pp. e5–e6, 2014. View at Publisher · View at Google Scholar · View at Scopus
  330. M. B. Furtado, M. W. Costa, E. A. Pranoto et al., “Cardiogenic genes expressed in cardiac fibroblasts contribute to heart development and repair,” Circulation Research, vol. 114, no. 9, pp. 1422–1434, 2014. View at Publisher · View at Google Scholar · View at Scopus
  331. S. S. Yadav, M. K. Singh, P. Dwivedi et al., “Significance of impaired serum gelatinases activities in metabolic syndrome,” Toxicology International, vol. 21, no. 1, pp. 107–111, 2014. View at Publisher · View at Google Scholar · View at Scopus
  332. Š. Tóth Jr., T. Pekárová, J. Varga et al., “Trehalase as a possible marker of intestinal ischemia—reperfusion injury,” Acta Biochimica Polonica, vol. 60, no. 3, pp. 411–416, 2013. View at Google Scholar · View at Scopus
  333. Q. Zhang, X. Xiao, M. Li et al., “Berberine moderates glucose metabolism through the GnRH-GLP-1 and MAPK pathways in the intestine,” BMC Complementary and Alternative Medicine, vol. 14, no. 1, p. 188, 2014. View at Publisher · View at Google Scholar
  334. P. Bialasiewicz, A. Prymont-Przyminska, A. Zwolinska et al., “Addition of strawberries to the usual diet decreases resting chemiluminescence of fasting blood in healthy subjects-possible health-promoting effect of these fruits consumption,” Journal of the American College of Nutrition, vol. 33, no. 4, pp. 274–287, 2014. View at Publisher · View at Google Scholar
  335. L. B. Gano, M. Patel, and J. M. Rho, “Ketogenic diets, mitochondria, and neurological diseases,” The Journal of Lipid Research, vol. 55, no. 11, pp. 2211–2228, 2014. View at Publisher · View at Google Scholar
  336. C. Parolini, R. Vik, M. Busnelli et al., “A salmon protein hydrolysate exerts lipid-independent anti-atherosclerotic activity in apoE-deficient mice,” PLoS ONE, vol. 9, no. 5, Article ID e97598, 2014. View at Publisher · View at Google Scholar · View at Scopus
  337. H. K. Vivek, S. G. Swamy, B. S. Priya, G. Sethi, K. S. Rangappa, and S. N. Swamy, “A facile assay to monitor secretory phospholipase A2 using 8-anilino-1-naphthalenesulfonic acid,” Analytical Biochemistry, vol. 461, pp. 27–35, 2014. View at Publisher · View at Google Scholar
  338. M. Shichiri, “The role of lipid peroxidation in neurological disorders,” Journal of Clinical Biochemistry and Nutrition, vol. 54, no. 3, pp. 151–160, 2014. View at Publisher · View at Google Scholar · View at Scopus
  339. B. D. Sahu, U. K. Putcha, M. Kuncha, S. S. Rachamalla, and R. Sistla, “Carnosic acid promotes myocardial antioxidant response and prevents isoproterenol-induced myocardial oxidative stress and apoptosis in mice,” Molecular and Cellular Biochemistry, vol. 394, no. 1-2, pp. 163–176, 2014. View at Publisher · View at Google Scholar · View at Scopus
  340. O. T. Le, T. T. Nguyen, and S. Y. Lee, “Phosphoinositide turnover in Toll-like receptor signaling and trafficking,” BMB Reports, vol. 47, no. 7, pp. 361–368, 2014. View at Publisher · View at Google Scholar
  341. Y. Keyamura, C. Nagano, M. Kohashi et al., “Add-on effect of probucol in atherosclerotic, cholesterol-fed rabbits treated with atorvastatin,” PLoS ONE, vol. 9, no. 5, Article ID e96929, 2014. View at Publisher · View at Google Scholar · View at Scopus
  342. C. Herrick, M. Litvin, and A. C. Goldberg, “Lipid lowering in liver and chronic kidney disease,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 28, no. 3, pp. 339–352, 2014. View at Publisher · View at Google Scholar · View at Scopus
  343. J. S. Albert, L. M. Yerges-Armstrong, R. B. Horenstein et al., “Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes,” The New England Journal of Medicine, vol. 370, no. 24, pp. 2307–2315, 2014. View at Publisher · View at Google Scholar
  344. E. Luongo, R. Russo, C. Avagliano et al., “Galactosyl prodrug of palmitoylethanolamide: Synthesis, stability, cell permeation and cytoprotective activity,” European Journal of Pharmaceutical Sciences, vol. 62, pp. 33–39, 2014. View at Publisher · View at Google Scholar
  345. R. K. Vinod, M. Shashikala, and K. P. Suresh, “Distribution of certain risk factors among dyslipidaemic patients, morbid with first episode coronary heart disease,” Journal of the Indian Medical Association, vol. 111, no. 6, pp. 391–394, 2013. View at Google Scholar · View at Scopus
  346. M. M. Page, D. A. Bell, A. J. Hooper, G. F. Watts, and J. R. Burnett, “Lipoprotein apheresis and new therapies for severe familial hypercholesterolemia in adults and children,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 28, no. 3, pp. 387–403, 2014. View at Publisher · View at Google Scholar · View at Scopus
  347. D. C. Chan, P. H. R. Barrett, and G. F. Watts, “The metabolic and pharmacologic bases for treating atherogenic dyslipidaemia,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 28, no. 3, pp. 369–385, 2014. View at Publisher · View at Google Scholar · View at Scopus
  348. P. P. Toth, P. K. Shah, M. J. Wilkinson, M. H. Davidson, and P. A. McCullough, “Use of microsomal triglyceride transfer protein inhibitors in patients with homozygous familial hypercholesterolemia: translating clinical trial experience into clinical practice,” Reviews in Cardiovascular Medicine, vol. 15, no. 1, pp. 1–10, 2014. View at Google Scholar
  349. M. S. Koozehchian, F. Nazem, R. B. Kreider et al., “The role of exercise training on lipoprotein profiles in adolescent males,” Lipids in Health and Disease, vol. 13, no. 1, article 95, 2014. View at Publisher · View at Google Scholar · View at Scopus
  350. M. M. Hussain, “Intestinal lipid absorption and lipoprotein formation,” Current Opinion in Lipidology, vol. 25, no. 3, pp. 200–206, 2014. View at Publisher · View at Google Scholar · View at Scopus
  351. J. Kim, Y.-S. Kim, H. A. Lee et al., “Sasa quelpaertensis leaf extract improves high fat diet-induced lipid abnormalities and regulation of lipid metabolism genes in rats,” Journal of Medicinal Food, vol. 17, no. 5, pp. 571–581, 2014. View at Publisher · View at Google Scholar · View at Scopus
  352. M.-L. Eggert, H. Wallaschofski, A. Grotevendt et al., “Cross-sectional and longitudinal relation of IGF1 and IGF-binding protein 3 with lipid metabolism,” European Journal of Endocrinology, vol. 171, no. 1, pp. 9–19, 2014. View at Publisher · View at Google Scholar
  353. K. Kwiatkowska, E. Marszałek-Sadowska, G. Traczyk et al., “Visualization of cholesterol deposits in lysosomes of Niemann-Pick type C fibroblasts using recombinant perfringolysin O,” Orphanet Journal of Rare Diseases, vol. 9, article 64, 2014. View at Publisher · View at Google Scholar · View at Scopus
  354. L. C. De Vos, D. J. Mulder, A. J. Smit et al., “Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 4, pp. 933–938, 2014. View at Publisher · View at Google Scholar · View at Scopus
  355. L. Lim, C. Banwell, C. Bain et al., “Sugar sweetened beverages and weight gain over 4 years in a Thai national cohort—a prospective analysis,” PLoS ONE, vol. 9, no. 5, Article ID e95309, 2014. View at Publisher · View at Google Scholar · View at Scopus